Kimball International (KBAL) 10-Q 5 May 22 2022 Q3 Quarterly report Financial data

Cover page

Cover page - shares	9 Months Ended
	Mar. 31, 2022	Apr. 28, 2022
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	0-3279
Entity Registrant Name	KIMBALL INTERNATIONAL, INC.
Entity Incorporation, State or Country Code	IN
Entity Tax Identification Number	35-0514506
Entity Address, Address Line One	1600 Royal Street
Entity Address, City or Town	Jasper
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47546-2256
City Area Code	(812)
Local Phone Number	482-1600
Title of 12(b) Security	Class B Common Stock, par value $0.05 per share
Trading Symbol	KBAL
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000055772
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		181,067
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		36,634,841

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Current Assets:
Cash and cash equivalents	$ 12,726	$ 24,336
Receivables, net of allowances of $1,040 and $1,121, respectively	71,495	58,708
Inventories	83,545	54,291
Prepaid expenses and other current assets	30,686	22,012
Total current assets	198,452	159,347
Property and equipment, net of accumulated depreciation of $191,299 and $191,757, respectively	92,542	90,623
Right-of-use operating lease assets	16,922	14,654
Goodwill	47,844	81,962
Other intangible assets, net of accumulated amortization of $48,344 and $41,796, respectively	59,911	64,478
Deferred tax assets	15,738	16,368
Other assets	17,193	17,163
Total Assets	448,602	444,595
Current Liabilities:
Current maturities of long-term debt	33	30
Accounts payable	70,446	41,537
Customer deposits	27,595	24,438
Current portion of operating lease liability	6,254	6,590
Dividends payable	3,688	3,532
Accrued expenses	37,081	39,115
Total current liabilities	145,097	115,242
Long-term debt, less current maturities	58,046	40,079
Long-term earn-out liability	4,440	20,190
Long-term operating lease liability	14,025	12,536
Other liabilities	14,994	16,878
Total other long-term liabilities	91,505	89,683
Shareholders’ Equity:
Additional paid-in capital	7,025	5,298
Retained earnings	268,836	299,034
Accumulated other comprehensive income	3,505	1,980
Less: Treasury stock, at cost, 6,222,000 shares and 6,148,000 shares, respectively	(69,517)	(68,793)
Total Shareholders’ Equity	212,000	239,670
Total Liabilities and Shareholders’ Equity	448,602	444,595
Class A Common Stock
Common stock-par value $0.05 per share:
Common Stock	9	9
Class B Common Stock
Common stock-par value $0.05 per share:
Common Stock	$ 2,142	$ 2,142

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) Parentheticals - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Receivables allowance	$ 1,040	$ 1,121
Accumulated depreciation	191,299	191,757
Accumulated Amortization	$ 48,344	$ 41,796
Treasury stock (in shares)	6,222,000	6,148,000
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	181,000	188,000
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.05	$ 0.05
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	42,842,000	42,835,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income (Loss) (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Net Sales	$ 180,918	$ 138,676	$ 488,931	$ 422,817
Cost of Sales	125,782	98,843	338,254	285,079
Gross Profit	55,136	39,833	150,677	137,738
Selling and Administrative Expenses	48,783	44,930	150,863	132,584
Other General (Income) Expense	(4,523)	0	(4,523)	0
Contingent Earn-out (Gain) Loss	2,150	0	(15,750)	0
Restructuring Expense	1,730	2,617	4,195	8,473
Goodwill impairment	0	0	34,118	0
Operating Income (Loss)	6,996	(7,714)	(18,226)	(3,319)
Other Income (Expense):
Interest income	25	59	77	248
Interest expense	(390)	(177)	(922)	(263)
Non-operating income (expense), net	(870)	311	(347)	2,434
Other income (expense), net	(1,235)	193	(1,192)	2,419
Income (Loss) Before Taxes on Income	5,761	(7,521)	(19,418)	(900)
Provision (Benefit) for Income Taxes	(534)	(2,992)	650	(919)
Net Income (Loss)	$ 6,295	$ (4,529)	$ (20,068)	$ 19
Earnings (Loss) Per Share of Common Stock:
Basic Earnings (Loss) Per Share (in dollars per share)	$ 0.17	$ (0.12)	$ (0.55)	$ 0
Diluted Earnings (Loss) Per Share (in dollars per share)	$ 0.17	$ (0.12)	$ (0.55)	$ 0
Class A and B Common Stock:
Average Number of Shares Outstanding - Basic (in shares)	36,795	36,860	36,788	36,932
Average Number of Shares Outstanding - Diluted (in shares)	37,061	36,860	36,788	37,529

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 6,295	$ (4,529)	$ (20,068)	$ 19
Available-for-sale securities
Available-for-sale securities, Pre-tax	0	(4)	0	(42)
Available-for-sale securities, Tax	0	1	0	11
Available-for-sale securities, Net of Tax	0	(3)	0	(31)
Postemployment severance actuarial change
Postemployment severance actuarial change, Pre-tax	251	174	814	476
Postemployment severance actuarial change, Tax	(66)	(45)	(211)	(123)
Postemployment severance actuarial change, Net of Tax	185	129	603	353
Unrealized gain (loss) on interest rate swap
Unrealized gain (loss) on interest rate swap, Pre-tax	1,345	0	1,446	0
Unrealized gain (loss) on interest rate swap, Tax	(347)	0	(373)	0
Unrealized gain (loss) on interest rate swap, Net of tax	998	0	1,073	0
Amortization of actuarial change
Amortization of actuarial change, Pre-tax	(129)	(112)	(399)	(333)
Amortization of actuarial change, Tax	34	29	103	86
Amortization of actuarial change, Net of Tax	(95)	(83)	(296)	(247)
Interest rate swap, Pre-tax	62	0	195	0
Interest rate swap, Tax	(16)	0	(50)	0
Interest rate swap, Net of Tax	46	0	145	0
Other comprehensive income (loss)
Other comprehensive income (loss), Pre-tax	1,529	58	2,056	101
Other comprehensive income (loss), Tax	(395)	(15)	(531)	(26)
Other comprehensive income (loss)	1,134	43	1,525	75
Total comprehensive income (loss)	$ 7,429	$ (4,486)	$ (18,543)	$ 94

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		9 Months Ended
		Mar. 31, 2022	Mar. 31, 2021
Cash Flows From Operating Activities:
Net income (loss)		$ (20,068)	$ 19
Adjustments to reconcile net income (loss) to net cash (used for) provided by operating activities:
Depreciation		10,820	10,836
Amortization		7,212	4,212
Gain on sales of assets		(4,537)	(165)
Restructuring and asset impairment charges		1,527	1,916
Deferred income tax and other deferred charges		95	(491)
Goodwill impairment		34,118	0
Stock-based compensation		3,708	4,048
Change in earn-out liability		(15,750)	0
Other, net		(2,528)	(1,440)
Change in operating assets and liabilities:
Receivables		(12,847)	24,055
Inventories		(29,254)	7,057
Prepaid expenses and other current assets		(7,928)	(1,991)
Accounts payable		27,600	(9,391)
Customer deposits		3,157	2,636
Accrued expenses		(1,927)	(13,971)
Net cash (used for) provided by operating activities		(6,602)	27,330
Cash Flows From Investing Activities:
Capital expenditures		(12,869)	(8,968)
Proceeds from sales of assets		5,498	498
Cash paid for acquisition		0	(101,478)
Purchases of capitalized software		(2,925)	(4,940)
Purchases of available-for-sale securities		0	(10,000)
Maturities of available-for-sale securities		0	14,750
Other, net		(50)	74
Net cash used for investing activities		(10,346)	(110,064)
Cash Flows From Financing Activities:
Proceeds from revolving credit facility		45,000	40,000
Payments on revolving credit facility		(27,000)	0
Repayments of long-term debt		(30)	(28)
Dividends paid to shareholders		(9,925)	(9,969)
Repurchases of Common Stock		(2,447)	(2,077)
Repurchase of employee shares for tax withholding		(590)	(258)
Net cash provided by financing activities		5,008	27,668
Net Decrease in Cash, Cash Equivalents, and Restricted Cash	[1]	(11,940)	(55,066)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash at Beginning of Period	[1]	25,727	92,444
Cash, Cash Equivalents, Restricted Cash and Restricted Cash at End of Period	[1]	13,787	37,378
Non-cash items:
Contingent earn-out liability upon Poppin, Inc. acquisition		0	31,790
Cash paid (refunded) during the period for:
Income taxes		(99)	6,239
Interest expense		$ 862	$ 211
[1]	The following table reconciles cash and cash equivalents in the balance sheets to cash, cash equivalents, and restricted cash per the statements of cash flows. The restricted cash included in other assets on the balance sheet represents amounts pledged as collateral for a long-term financing arrangement as contractually required by a lender. The restriction will lapse when the related debt is paid. Restricted cash also included customer deposits held due to a foreign entity being classified as a restricted entity by a government agency subsequent to our receipt of the deposit and cash held in escrow for repayment of the Payment Protection Program loan that Poppin, Inc. obtained prior to its acquisition.

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (unaudited) - Cash Reconciliation - USD ($) $ in Thousands		Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2020
Statement of Cash Flows [Abstract]
Cash and cash equivalents		$ 12,726	$ 24,336	$ 33,451	$ 91,798
Restricted cash included in Other Assets		1,061	1,391	3,927	646
Total Cash, Cash Equivalents, and Restricted Cash at end of period	[1]	$ 13,787	$ 25,727	$ 37,378	$ 92,444
[1]	The following table reconciles cash and cash equivalents in the balance sheets to cash, cash equivalents, and restricted cash per the statements of cash flows. The restricted cash included in other assets on the balance sheet represents amounts pledged as collateral for a long-term financing arrangement as contractually required by a lender. The restriction will lapse when the related debt is paid. Restricted cash also included customer deposits held due to a foreign entity being classified as a restricted entity by a government agency subsequent to our receipt of the deposit and cash held in escrow for repayment of the Payment Protection Program loan that Poppin, Inc. obtained prior to its acquisition.

Condensed Consolidated Statem_5

Condensed Consolidated Statement of Shareowners' Equity (unaudited) Statement - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common StockClass A Common Stock	Common StockClass B Common Stock	Additional Paid-In Capital	Retained Earnings	Retained EarningsCumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income	Treasury Stock
Balance at the beginning of the period at Jun. 30, 2020	$ 244,796	$ 134	$ 10	$ 2,141	$ 3,770	$ 305,024	$ 134	$ 2,137	$ (68,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	19					19
Other comprehensive income (loss)	75							75
Issuance of unrestricted shares	(24)				(511)				487
Conversion of Class A to Class B common stock	0		(1)	1
Compensation expense related to stock compensation plans	4,048				4,048
Restricted stock units issuance	(80)				(284)				204
Relative total shareholder return performance units issuance	(156)				(586)				430
Repurchase of Common Stock	(2,192)								(2,192)
Dividends declared	(10,161)					(10,161)
Balance at the end of the period at Mar. 31, 2021	236,459		9	2,142	6,437	295,016		2,212	(69,357)
Balance at the beginning of the period at Dec. 31, 2020	244,012		9	2,142	4,843	302,937		2,169	(68,088)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(4,529)					(4,529)
Other comprehensive income (loss)	43							43
Issuance of unrestricted shares	(24)				(196)				172
Conversion of Class A to Class B common stock	0		0	0
Compensation expense related to stock compensation plans	1,790				1,790
Repurchase of Common Stock	(1,441)								(1,441)
Dividends declared	(3,392)					(3,392)
Balance at the end of the period at Mar. 31, 2021	236,459		9	2,142	6,437	295,016		2,212	(69,357)
Balance at the beginning of the period at Jun. 30, 2021	239,670		9	2,142	5,298	299,034		1,980	(68,793)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(20,068)					(20,068)
Other comprehensive income (loss)	1,525							1,525
Issuance of unrestricted shares	162				(235)				397
Conversion of Class A to Class B common stock	0		0	0
Compensation expense related to stock compensation plans	3,708				3,708
Restricted stock units issuance	(506)				(1,642)				1,136
Relative total shareholder return performance units issuance	(32)				(104)				72
Repurchase of Common Stock	(2,329)								(2,329)
Dividends declared	(10,130)					(10,130)
Balance at the end of the period at Mar. 31, 2022	212,000		9	2,142	7,025	268,836		3,505	(69,517)
Balance at the beginning of the period at Dec. 31, 2021	206,664		9	2,142	6,015	265,924		2,371	(69,797)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,295					6,295
Other comprehensive income (loss)	1,134							1,134
Issuance of unrestricted shares	165				7				158
Compensation expense related to stock compensation plans	1,153				1,153
Restricted stock units issuance	(28)				(150)				122
Dividends declared	(3,383)					(3,383)
Balance at the end of the period at Mar. 31, 2022	$ 212,000		$ 9	$ 2,142	$ 7,025	$ 268,836		$ 3,505	$ (69,517)

Condensed Consolidated Statem_6

Condensed Consolidated Statement of Shareowners' Equity (unaudited) Parentheticals - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Statement of Stockholders' Equity [Abstract]
Issuance of non-restricted stock (in shares)	12,000	13,000	30,000	37,000
Conversion of Class A to Class B common stock (in shares)		1,000	5,000	2,000
Vesting of restricted stock units (in shares)	9,000		87,000	15,000
Relative total shareholder return performance units issuance (in shares)			5,000	32,000
Repurchase of Common Stock (in shares)		109,000	196,000	171,000
Dividends declared (in dollars per share)	$ 0.09	$ 0.09	$ 0.27	$ 0.27
Total Shareholders’ Equity	$ 212,000	$ 236,459	$ 212,000	$ 236,459

Basis of Presentation

Basis of Presentation	9 Months Ended
	Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of PresentationThe accompanying unaudited Condensed Consolidated Financial Statements of Kimball International, Inc. (the “Company,” “Kimball International,” “we,” “us,” or “our”) have been prepared in accordance with the instructions to Form 10-Q. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. Intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in our latest annual report on Form 10-K. Additionally, based on the duration and severity of the current global situation involving the COVID-19 pandemic, related supply chain disruptions and inflation, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.

Recent Accounting Pronouncement

Recent Accounting Pronouncements and Supplemental Information	9 Months Ended
	Mar. 31, 2022
Recent Accounting Pronouncements and Supplemental Information [Abstract]
Recent Accounting Pronouncements and Supplemental Information	Recent Accounting Pronouncements and Supplemental Information Recently Issued Accounting Pronouncements Not Yet Adopted: In October 2021, the Financial Accounting Standards Board issued guidance on accounting for contract assets and contract liabilities, related to revenue contracts with customers, during a business combination by the acquiring business entity. The acquirer is to measure the contract asset and contract liability as of the acquisition date as if the acquirer had originated the contracts. This is a departure from the current practice under U.S. GAAP of recognizing contract assets and contract liabilities at fair value as of the acquisition date. The guidance will be effective in our first quarter of fiscal year 2024, though early adoption is permitted. Management is unable to predict whether the adoption of this guidance will have a material impact on our financial statements. Goodwill and Other Intangible Assets: Goodwill represents the difference between the purchase price and the related underlying tangible and intangible net asset fair values resulting from business acquisitions. Goodwill is assigned to and the fair value is tested at the reporting unit level. Annually, or if conditions indicate an earlier assessment is necessary, we may assess qualitative factors to determine if it is more likely than not that the fair value is less than its carrying amount. We also have the option to bypass the qualitative assessment and proceed directly to performing the quantitative goodwill impairment test which compares the carrying value of the reporting unit to the reporting unit’s fair value to identify impairment. Under the quantitative assessment, if the fair value of the reporting unit is less than the carrying value, goodwill is written down to its fair value. The fair value is established primarily using a discounted cash flow analysis and secondarily a market approach utilizing current industry information. The calculation of the fair value of the reporting unit considers current market conditions existing at the assessment date and reporting unit specific scenarios weighted on probability of outcome. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, and determination of our weighted average cost of capital. The estimates used to calculate the fair value of a reporting unit change from year to year based on operating results, market conditions, and other factors. Changes in these estimates and assumptions could materially affect the determination of fair value and goodwill impairment for each reporting unit. While we have historically performed goodwill impairment testing annually during the second fiscal quarter, changes in circumstances may require an interim assessment of the carrying amounts of our reporting units relative to their fair values. In connection with our annual goodwill impairment test and the preparation of our financial statements, we assessed goodwill at the reporting unit level for impairment during our second quarter of fiscal year 2022 and based on our analysis our Poppin reporting unit had a carrying amount that exceeded its fair value. A forecast revision to delay future sales and earnings growth of the Poppin reporting unit drove the decline in the fair value of the reporting unit, which was primarily attributable to changes in demand due to the ongoing COVID-19 pandemic and supply chain constraints. As a result, we recorded a goodwill impairment loss of $34.1 million during the second quarter of fiscal year 2022, as further discussed in Note 13. Fair Value of Notes to Condensed Consolidated Financial Statement. The changes in the carrying amount of goodwill are summarized as follows: (Amounts in Thousands) Gross Goodwill Accumulated Impairment Net Carrying Amount June 30, 2020 $ 12,893 $ (1,733) $ 11,160 Additions 70,802 — 70,802 June 30, 2021 83,695 (1,733) 81,962 Impairment — (34,118) (34,118) March 31, 2022 $ 83,695 $ (35,851) $ 47,844 See Note 3 - Acquisition of Notes to Condensed Consolidated Financial Statements for more information on this acquisition. Other Intangible Assets reported on the Condensed Consolidated Balance Sheets consist of capitalized software, customer relationships, trade names, acquired technology, patents and trademarks, and non-compete agreements. Intangible assets are assessed for impairment when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets. As a result of the downward revision in the forecasted operations of Poppin, management identified that a triggering event had occurred, indicating that certain long lived assets may not be recoverable. The intangible assets of the Poppin reporting unit were assessed for impairment during the second quarter of fiscal year 2022, and no impairment was identified. A summary of intangible assets subject to amortization is as follows: March 31, 2022 June 30, 2021 (Amounts in Thousands) Cost Accumulated Net Value Cost Accumulated Net Value Capitalized Software $ 45,181 $ 34,992 $ 10,189 $ 43,200 $ 34,058 $ 9,142 Customer Relationships 19,050 6,016 13,034 19,050 3,936 15,114 Trade Names 36,570 5,897 30,673 36,570 3,154 33,416 Acquired Technology 7,000 1,312 5,688 7,000 559 6,441 Patents and Trademarks 354 39 315 354 16 338 Non-Compete Agreements 100 88 12 100 73 27 Other Intangible Assets $ 108,255 $ 48,344 $ 59,911 $ 106,274 $ 41,796 $ 64,478 A summary of the useful lives of intangible assets subject to amortization is as follows: Years Capitalized Software 2 to 13 Customer Relationships 10 to 20 Trade Names 10 Acquired Technology 7 Patents 14 Trademarks 15 Non-Compete Agreements 5 Amortization expense related to intangible assets was, in thousands, $2,358 and $7,212 during the quarter and year-to-date period ended March 31, 2022, and was, in thousands, $2,510 and $4,212 during the quarter and year-to-date period ended March 31, 2021. Amortization expense in future periods is expected to be, in thousands, $2,462 for the remainder of fiscal year 2022, and $9,060, $8,454, $8,167, and $7,716 in the four years ending June 30, 2026, and $24,051 thereafter. Capitalized software is stated at cost less accumulated amortization and is amortized using the straight-line method. During the software application development stage, capitalized costs include external consulting costs, cost of software licenses, and internal payroll and payroll-related costs for employees who are directly associated with a software project. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process re-engineering costs are expensed in the period in which they are incurred. Trade names, non-compete agreements, acquired technology, patents and trademarks are amortized on a straight-line basis over their estimated useful lives. Customer relationships are amortized based on estimated attrition rates of customers. We have no intangible assets with indefinite useful lives which are not subject to amortization. Other General (Income) Expense: Other General (Income) Expense includes the gain related to the sale of a warehouse during the third quarter of fiscal year 2022. Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Other General (Income) Expense $ (4,523) $ — $ (4,523) $ — Non-operating Income (Expense), net: Non-operating income and expense include the impact of such items as fair value adjustments on Supplemental Employee Retirement Plan (“SERP”) investments, amortization of actuarial income, foreign currency rate movements, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain or loss on SERP investments is offset by a change in the SERP liability that is recognized in selling and administrative expenses. Components of the Non-operating income (expense), net line, were: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Gain (Loss) on SERP Investments $ (887) $ 428 $ (300) $ 2,567 Other 17 (117) (47) (133) Non-operating income (expense), net $ (870) $ 311 $ (347) $ 2,434

Acquisition

Acquisition	9 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Acquisition	Acquisition On December 9, 2020, we acquired Poppin, Inc. (“Poppin”), a tech-enabled, market-leading B2B commercial furniture design company headquartered in New York City, New York. Poppin designs commercial-grade furniture that is made to mix, match, and scale in today’s modern office and work-from-home environments. The acquisition purchase price totaled $110.4 million in initial cash consideration plus $31.8 million in contingent earn-out consideration as valued at the date of acquisition. The contingent earn-out is payable on annual revenue and profitability milestones achieved through June 30, 2024. As of March 31, 2022 and June 30, 2021, the fair value of the contingent earn-out liability was $4.4 million and $20.2 million, respectively. A summary of the final purchase price allocation is as follows: Purchase Price Allocation (Amounts in Thousands) Cash $ 5,768 Receivables 2,814 Inventories 15,718 Other current assets 700 Net property and equipment 975 Other intangible assets 52,394 Goodwill 70,801 Right-of-use operating lease assets 5,103 Other long-term assets 4,161 Deferred tax assets 5,836 Total Assets $ 164,270 Current maturities of long-term debt 1,252 Accounts payable 7,715 Customer deposits 2,045 Current portion of operating lease liability 1,937 Accrued expenses 5,260 Long-term debt, less current maturities 1,252 Long-term operating lease liability 2,565 Other long-term liabilities 80 Total Liabilities $ 22,106 Net Assets $ 142,164 Consideration (Amounts in Thousands) Cash $ 110,374 Contingent earn-out — fair value at acquisition date 31,790 Fair value of total consideration $ 142,164 Less: Acquired cash 5,768 Total consideration less acquired cash $ 136,396 Goodwill is primarily attributable to the anticipated supply chain and revenue synergies including cross selling initiatives expected from the operations of the combined company. The goodwill is not deductible for tax purposes. See Note 2 - Recent Accounting Pronouncements and Supplemental Information of Notes to Condensed Consolidated Financial Statements for more information on goodwill and other intangible assets, including the goodwill impairment charge recognized during the second quarter of fiscal year 2022. The purchase price allocation was final as of September 30, 2021. The operating results of this acquisition are included in our consolidated financial statements beginning on December 9, 2020. For the third quarter of fiscal year 2022, net sales and net loss related to Poppin were $17.2 million of net sales and $3.6 million of net loss. For the year-to-date period ending March 31, 2022, net sales and net losses related to Poppin were $45.9 million of net sales and $10.6 million of net loss. The aforementioned net losses include amortization on acquired intangibles and exclude earn-out adjustments related to operating performance and goodwill impairment after the acquisition date. There were no direct acquisition costs during the quarter and year-to-date periods ended March 31, 2022. Pro Forma Information The following unaudited pro forma financial information summarizes the combined results of operations for Kimball International, Inc. and Poppin, Inc. as if the companies were combined as of the beginning of fiscal period presented below: (unaudited) Nine months ended March 31 (Amounts in Thousands, Except Per Share Data) 2021 Net Sales $ 442,966 Net Income (Loss) (3,187) Diluted Earnings (Loss) Per Share of Common Stock $ (0.08) This pro forma financial information is based on historical results of operations, adjusted for the allocation of the purchase price and other acquisition accounting adjustments. This pro forma information is not necessarily indicative of what our results would have been had we operated the businesses since the beginning of the period presented. The pro forma adjustments reflect the income statement effects of amortization of intangibles related to the fair value adjustments of the assets acquired, acquisition-related costs, incremental interest expense, and the related tax effects.

Restructuring

Restructuring	9 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring	Restructuring We recognized pre-tax restructuring expense of $1.7 million and $4.2 million in the three and nine months ended March 31, 2022, and recognized $2.6 million and $8.5 million for the three and nine months ended March 31, 2021. We utilized available market prices and management estimates to determine the fair value of impaired assets. Restructuring is included in the Restructuring Expense line item on our Condensed Consolidated Statements of Income. Transformation Restructuring Plan: Included in the current phase of our transformation restructuring plan are activities such as the streamlining of manufacturing facilities, voluntary retirement incentive programs, and the consolidation of showrooms. This phase of the transformation restructuring plan began in the first quarter of our fiscal year 2021, and we expect a substantial majority of the restructuring actions to be completed by the end of fiscal year 2023. In addition to the savings already generated from the first phase of the transformation restructuring plan, the efforts of this second phase of the transformation restructuring plan are expected to generate annualized pre-tax savings of approximately $18.0 million when it is fully implemented. We currently estimate this phase of the transformation restructuring plan will incur total pre-tax restructuring charges of approximately $17.5 million to $18.5 million, with approximately $6.0 million expected to be recorded in fiscal year 2022, and approximately $3.5 million thereafter. The restructuring charges are expected to consist of approximately $5.5 million to $6.0 million for severance and other employee-related costs, $6.0 million to $6.2 million for facility costs, and $6.0 million to $6.3 million for lease and other asset impairment. Approximately 65% of the total cost estimate is expected to be cash expense. A summary of the charges recorded in connection with the second phase of the transformation restructuring plan is as follows: Three Months Ended Nine Months Ended Charges Incurred to Date March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Cash-related restructuring charges: Severance and other employee related costs $ 539 $ 1,404 $ 772 $ 4,915 $ 5,854 Facility exit costs and other cash charges 1,006 613 1,896 849 3,483 Total cash-related restructuring charges $ 1,545 $ 2,017 $ 2,668 $ 5,764 $ 9,337 Non-cash charges: Impairment of assets and accelerated depreciation 185 452 1,527 1,437 3,683 Total charges $ 1,730 $ 2,469 $ 4,195 $ 7,201 $ 13,020 A summary of the current period activity in accrued restructuring related to the second phase of the transformation restructuring plan is as follows: (Amounts in Thousands) Severance and other employee related costs Balance at June 30, 2021 $ 1,386 Additions charged to expense 788 Cash payments charged against reserve (1,645) Non-cash adjustments (25) Balance at March 31, 2022 $ 504

Revenue

Revenue	9 Months Ended
	Mar. 31, 2022
Revenue Recognition [Abstract]
Revenue	Revenue Disaggregation of Revenue The following table provides information about revenue by operating segment: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Millions) 2022 2021 2022 2021 Workplace $ 102.5 $ 70.0 $ 290.2 $ 249.9 Health 26.6 24.6 76.2 72.2 Hospitality 34.5 35.2 76.4 89.0 eBusiness 17.3 8.9 46.1 11.7 Total Net Sales $ 180.9 $ 138.7 $ 488.9 $ 422.8 We report revenue under a single aggregated reportable segment consisting of four operating segments which have similar products and services in nature, utilize similar production and distribution processes, and share similar long-term economic characteristics. Contract Balances Receivables in the Condensed Consolidated Balance Sheets represent the amount of consideration to which we are entitled in exchange for the goods or services sold to our customers, net of allowances for doubtful accounts. Receivables are recorded when the right to consideration from the customer becomes unconditional, which is generally upon billing or upon satisfaction of a performance obligation, whichever is earlier. We also receive deposits from certain customers before revenue is recognized, resulting in the recognition of a contract liability reported as Customer Deposits in the Condensed Consolidated Balance Sheets. Customer deposits are typically utilized within a year of the receipt of the deposit. The amount of revenue recognized during the nine months ended March 31, 2022 that was included in the June 30, 2021 customer deposit balance was $23.5 million.

Leases

Leases	9 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Leases We have operating leases for showrooms, manufacturing facilities, warehouses, certain offices, and other facilities to support our operations in addition to select equipment that expire at various dates through fiscal year 2030. We have no financing leases. Certain operating lease agreements include rental payments adjusted periodically for inflationary indices. Additionally, some leases include options to renew or terminate the leases which can be exercised at our discretion. Lease terms include the noncancellable portion of the underlying leases along with any reasonably certain lease periods associated with available renewal periods. Certain leases have terms that are dependent upon the occurrence of events, activities, or circumstances in lease agreements and incur variable lease expense driven by warehouse square footage utilized, property taxes assessed, and other non-lease component charges. Variable lease expense is presented as operating expense in our Condensed Consolidated Statements of Income and Comprehensive Income in the same line item as expense arising from fixed lease payments for operating leases. For all classes of assets, we do not separate non-lease components of a contract from the lease components to which they relate. We do not recognize a right-of-use asset or lease liability for short-term leases that have a lease term of twelve months or less. The components of our lease expenses are as follows: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Millions) 2022 2021 2022 2021 Operating lease expense $ 1.2 $ 1.3 $ 3.6 $ 3.1 Variable lease expense 1.1 1.2 2.8 2.5 Total lease expense $ 2.3 $ 2.5 $ 6.4 $ 5.6 Right-of-use assets for operating leases are tested for impairment in the same manner as long-lived assets used in operations as explained in Note 13 - Fair Value of Notes to Condensed Consolidated Financial Statements. During the first nine months of fiscal years 2022 and 2021, we recorded $0.7 million and $0.2 million of right-of-use asset and associated leasehold improvement impairments, respectively. The impairment charges are included in the Restructuring Expense line item on our Condensed Consolidated Statements of Income. See Note 4 - Restructuring of Notes to Condensed Consolidated Financial Statements for more information on the impairments. Supplemental cash flow and other information related to leases are as follows: Nine Months Ended March 31 (Amounts in Millions) 2022 2021 Cash flow information: Operating lease payments impacting lease liability $ 5.8 $ 4.2 Non-cash impact of obtaining new right-of-use assets $ 6.3 $ 5.1 As of March 31 2022 2021 Other information: Weighted-average remaining term (in years) 4.8 4.4 Weighted-average discount rate 4.4 % 4.5 % The following table summarizes the future minimum lease payments as of March 31, 2022: Fiscal Year Ended (Amounts in Millions) June 30 (1) 2022 $ 1.5 2023 6.0 2024 4.5 2025 3.8 2026 2.8 Thereafter 3.9 Total lease payments $ 22.5 Less interest 2.2 Present value of lease liabilities $ 20.3 (1) Lease payments include options to extend lease terms that are reasonably certain of being exercised. In fiscal year 2021, we executed a contract to sell a warehouse which was accounted for as a failed sale leaseback as control did not pass to the buyer. During the third quarter of fiscal year 2022 we received payment and control passed to the buyer, and we recorded a pre-tax gain on sale of the warehouse of $4.5 million. The gain was recorded in the Other General (Income) Expense line item in the Condensed Consolidated Statements of Income.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per ShareBasic earnings per share are based on the weighted average number of shares outstanding during the period. Diluted earnings per share are based on the weighted average number of shares outstanding plus the assumed issuance of common shares for all potentially dilutive securities. Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands, Except for Per Share Data) 2022 2021 2022 2021 Net Income (Loss) $ 6,295 $ (4,529) $ (20,068) $ 19 Average Shares Outstanding for Basic EPS Calculation 36,795 36,860 36,788 36,932 Dilutive Effect of Average Outstanding Compensation Awards 266 — — 597 Average Shares Outstanding for Diluted EPS Calculation 37,061 36,860 36,788 37,529 Basic Earnings (Loss) Per Share $ 0.17 $ (0.12) $ (0.55) $ 0.00 Diluted Earnings (Loss) Per Share $ 0.17 $ (0.12) $ (0.55) $ 0.00

Income Taxes

Income Taxes	9 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesIn determining the quarterly provision for income taxes we use an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur. Our effective tax rates for the three and nine months ended March 31, 2022 were negative tax rates of (9.3)% and (3.3)%, respectively, driven by the book versus tax treatment of nondeductible goodwill impairment and earn-out valuation adjustments. Our effective tax rate for the three and nine months ended March 31, 2021 were 39.8% and 102.1%, respectively. These rates were higher than the combined federal and state statutory tax rate primarily due to R&D tax credits, which increased the tax benefit associated with the pre-tax losses during the quarter and year-to-date periods.

Inventories

Inventories	9 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories Inventory components were as follows: (Amounts in Thousands) March 31, June 30, Finished products $ 56,235 $ 37,787 Work-in-process 1,829 1,320 Raw materials 48,988 33,428 Total FIFO inventory 107,052 72,535 LIFO reserve (23,507) (18,244) Total inventory $ 83,545 $ 54,291

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Income During the three months ended March 31, 2022 and 2021, the changes in the balances of each component of Accumulated Other Comprehensive Income, net of tax, were as follows: Accumulated Other Comprehensive Income (Amounts in Thousands) Unrealized Investment Gain (Loss) Postemployment Benefits Net Actuarial Gain (Loss) Interest Rate Swap Gain (Loss) Accumulated Other Comprehensive Income Balance at December 31, 2021 $ — $ 2,197 $ 174 $ 2,371 Other comprehensive income (loss) before reclassifications — 185 998 1,183 Reclassification to (earnings) loss — (95) 46 (49) Net current-period other comprehensive income (loss) — 90 1,044 1,134 Balance at March 31, 2022 $ — $ 2,287 $ 1,218 $ 3,505 Balance at December 31, 2020 $ 4 $ 2,165 $ — $ 2,169 Other comprehensive income (loss) before reclassifications (3) 129 — 126 Reclassification to (earnings) loss — (83) — (83) Net current-period other comprehensive income (loss) (3) 46 — 43 Balance at March 31, 2021 $ 1 $ 2,211 $ — $ 2,212 During the nine months ended March 31, 2022 and 2021, the changes in the balances of each component of Accumulated Other Comprehensive Income, net of tax, were as follows: Accumulated Other Comprehensive Income (Amounts in Thousands) Unrealized Investment Gain (Loss) Postemployment Benefits Net Actuarial Gain (Loss) Interest Rate Swap Gain (Loss) Accumulated Other Comprehensive Income Balance at June 30, 2021 $ — $ 1,980 $ — $ 1,980 Other comprehensive income (loss) before reclassifications — 603 1,073 1,676 Reclassification to (earnings) loss — (296) 145 (151) Net current-period other comprehensive income (loss) — 307 1,218 1,525 Balance at March 31, 2022 $ — $ 2,287 $ 1,218 $ 3,505 Balance at June 30, 2020 $ 32 $ 2,105 $ — $ 2,137 Other comprehensive income (loss) before reclassifications (31) 353 — 322 Reclassification to (earnings) loss — (247) — (247) Net current-period other comprehensive income (loss) (31) 106 — 75 Balance at March 31, 2021 $ 1 $ 2,211 $ — $ 2,212 The following reclassifications were made from Accumulated Other Comprehensive Income to the Condensed Consolidated Statements of Income (Loss): Reclassifications from Accumulated Other Comprehensive Income Three Months Ended Nine Months Ended Affected Line Item in the Condensed Consolidated Statements of Income (Loss) March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Postemployment Benefits Amortization of Actuarial Gain (1) $ 129 $ 112 $ 399 $ 333 Non-operating income (expense), net (34) (29) (103) (86) Benefit (Provision) for Income Taxes $ 95 $ 83 $ 296 $ 247 Net Income (Loss) Interest Rate Swap Gain (Loss) (2) $ (62) $ — $ (195) $ — Interest expense 16 — 50 — Benefit (Provision) for Income Taxes $ (46) $ — $ (145) $ — Net Income (Loss) Total Reclassifications for the Period $ 49 $ 83 $ 151 $ 247 Net Income (Loss) Amounts in parentheses indicate reductions to income. (1) See Note 16 - Postemployment Benefits of Notes to Condensed Consolidated Financial Statements for further information on postemployment benefit plans. (2) See Note 15 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements for further information on derivative instruments.

Long-Term Debt and Revolving Cr

Long-Term Debt and Revolving Credit Facility	9 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt and Revolving Credit Facility	Long-Term Debt and Revolving Credit Facility Short-term borrowings and long-term debt consisted of the following obligations: (Amounts in Thousands) March 31, June 30, Long-term debt under revolving credit facility due October 2024; 2.46% variable interest rate at March 31, 2022 $ 58,000 $ 40,000 Other debt maturing August 2024; 9.25% fixed interest rate 79 109 Total Debt $ 58,079 $ 40,109 Aggregate maturities of long-term debt for the next three years through maturity are, in thousands, $33, $36 and $58,010, respectively. As of March 31, 2022 we had a $125.0 million revolving credit facility with a maturity date of October 2024 that allowed for both issuances of letters of credit and cash borrowings. We also have an option to request an increase of the amount available for borrowing to $200.0 million, subject to participating banks’ consent. The revolving loans under the Credit Agreement could consist of, at our election, advances in U.S. dollars or advances in any other currency that was agreed to by the lenders. The proceeds of the loans are to be used for general corporate purposes including acquisitions. A portion of the revolving credit facility, not to exceed $10.0 million of the principal amount, was available for the issuance of letters of credit. At March 31, 2022, we had $1.5 million in letters of credit outstanding, which reduced our borrowing capacity on the revolving credit facility. Total availability to borrow under the revolving credit facility was $65.5 million at March 31, 2022. The commitment fee on the unused portion of principal amount of the revolving credit facility is payable at a rate that ranges from 20 to 30 basis points per annum as determined by our ratio of consolidated total indebtedness to adjusted consolidated EBITDA. We were in compliance with all debt covenants of the revolving credit facility during the nine-month period ended March 31, 2022. During the first quarter of fiscal year 2022, we entered into a Second Amendment to Credit Agreement which amended our credit agreement by adding content to facilitate a transition to a base interest rate index other than the London Interbank Offered Rate and to define the provisions by which an overpayment or erroneous payment may be requested and returned to us. We have an interest rate swap agreement with a bank with a notional value of $40.0 million. The interest rate swap became effective in July 2021 and is accounted for using hedge accounting.

Commitments and Contingent Liab

Commitments and Contingent Liabilities	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	Commitments and Contingent Liabilities Guarantees: Standby letters of credit were issued to lessors and insurance institutions and can only be drawn upon in the event of our failure to pay our obligations to a beneficiary. As of March 31, 2022, we had a maximum financial exposure from unused standby letters of credit totaling $1.5 million. We are not aware of circumstances that would require us to perform under these arrangements and believe that the resolution of any claims that might arise in the future, either individually or in the aggregate, would not materially affect our Condensed Consolidated Financial Statements. Accordingly, no liability has been recorded as of March 31, 2022 with respect to the standby letters of credit. We also enter into commercial letters of credit to facilitate payments to vendors and from customers. Product Warranties: We provide an assurance-type warranty that guarantees our product complies with agreed-upon specifications. This warranty is not sold separately and does not convey any additional services to the customer. We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability periodically based on changes in historical cost trends and in certain cases where specific warranty issues become known. The product warranty liability is included on the Accrued Expenses and Other lines of our Condensed Consolidated Balance Sheets. Changes in the product warranty accrual for the nine months ended March 31, 2022 and 2021 were as follows: Nine Months Ended March 31 (Amounts in Thousands) 2022 2021 Product Warranty Liability at the beginning of the period $ 2,861 $ 3,190 Additions to warranty accrual (including changes in estimates) 882 1,256 Settlements made (in cash or in kind) (1,510) (1,643) Product Warranty Liability at the end of the period $ 2,233 $ 2,803

Fair Value

Fair Value	9 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value	Fair Value We categorize assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: • Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. • Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. Our policy is to recognize transfers between these levels as of the end of each quarterly reporting period. There were no transfers between these levels during the nine months ended March 31, 2022 and 2021. There were no changes in the inputs or valuation techniques used to measure fair values compared to those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. In connection with the acquisition of Poppin, remaining contingent earn-out payments up to $65.0 million may be paid based on revenue and profitability milestones achieved through June 30, 2024, with the expected payments to be in the range of $0 to $5 million. As of March 31, 2022 and June 30, 2021, the fair value of the contingent earn-out liability was $4.4 million and $20.2 million, respectively. The liability is carried at fair value and is classified in Level 3 of the fair value hierarchy. During the three and nine months ended March 31, 2022, the recurring revaluation to fair value resulted in a loss of $2.2 million and a gain of $15.8 million, respectively. The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs: Contingent Consideration Liability Fair Value Valuation Technique Unobservable Inputs Range Selected Revenue and EBITDA Based Payments $ 4.4 million Discounted Cash Flow Revenue Discount Rate 5.0% to 7.0% 5.8 % EBITDA Volatility 40.0% to 50.0% 45.0 % Revenue Volatility 8.0% to 11.0% 10.5 % Financial Instruments Recognized at Fair Value: The following methods and assumptions were used to measure fair value: Financial Instrument Level Valuation Technique/Inputs Used Cash Equivalents: Money market funds 1 Market - Quoted market prices Trading securities: Mutual funds held in nonqualified SERP 1 Market - Quoted market prices Derivative Assets: Stock warrants 3 Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities. Derivative Asset: Interest Rate Swap 2 Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball International's non-performance risk. Contingent earn-out liability 3 Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability. Recurring Fair Value Measurements: As of March 31, 2022 and June 30, 2021, the fair values of financial assets that are measured at fair value on a recurring basis using the market or income approach are categorized as follows: March 31, 2022 (Amounts in Thousands) Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 2,008 $ — $ — $ 2,008 Derivatives: Interest rate swap contract — 1,640 — 1,640 Trading Securities: Mutual funds in nonqualified SERP 13,113 — — 13,113 Derivatives: Stock warrants — — 1,500 1,500 Total assets at fair value $ 15,121 $ 1,640 $ 1,500 $ 18,261 Liabilities Contingent earn-out liability — — 4,440 4,440 Total liabilities at fair value $ — $ — $ 4,440 $ 4,440 June 30, 2021 (Amounts in Thousands) Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 18,762 $ — $ — $ 18,762 Trading Securities: Mutual funds in nonqualified SERP 14,049 — — 14,049 Derivatives: Stock warrants — — 1,500 1,500 Total assets at fair value $ 32,811 $ — $ 1,500 $ 34,311 Liabilities Contingent earn-out liability — — 20,190 20,190 Total liabilities at fair value $ — $ — $ 20,190 $ 20,190 Non-Recurring Fair Value Measurements: Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments when events or circumstances indicate a significant adverse effect on the fair value of the asset. Assets that are written down to fair value when impaired are not subsequently adjusted to fair value unless further impairment occurs. Non-recurring Fair Value Adjustment Level Valuation Technique/Inputs Used Impairment of Right of Use Lease Assets and Related Asset Groups 3 Income - Based on a valuation model that measures the present value of remaining lease payments less estimated sublease income at a discount rate that captures the risk associated with the future cash flows. Impairment of Goodwill 3 Income - Based on a valuation model that determines fair value based on estimated discounted future cash flows of each reporting unit, requiring the use of significant estimates and assumptions, including revenue growth rates and EBITDA margins, future market conditions and discount rates that capture the risk associated with future cash flows. During the year-to-date period of fiscal years 2022 and 2021, we recorded $0.7 million and $0.2 million, respectively of right-of-use asset and associated leasehold improvement impairment resulting from closure of our leased Pennsylvania and Maryland facilities as part of our transformation restructuring plan. The impairment loss is included as a component of the Restructuring Expense line item on our Condensed Consolidated Statements of Income. The asset groups used to calculate impairment included the right-of-use lease assets, leasehold improvements, and lease liabilities. In connection with our annual goodwill impairment test, we assessed goodwill at the reporting unit level for impairment during our second quarter of fiscal year 2022 ended December 31, 2021, and based on our analysis our Poppin reporting unit had carrying value in excess of the calculated fair value. Annual goodwill impairment testing determined the carrying value of the Poppin reporting unit exceeded its relative fair value, most notably driven by the impact of COVID-19 and supply chain disruptions on our sales growth models. As a result, we recorded $34.1 million of goodwill impairment related to our Poppin business during the year-to-date period ended March 31, 2022. The impairment loss is included in the Goodwill Impairment line item on our Condensed Consolidated Statements of Income. Financial Instruments Not Carried At Fair Value: Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following: Financial Instrument Level Valuation Technique/Inputs Used Notes receivable 2 Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer’s non-performance risk. Equity securities without readily determinable fair value 3 Cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively. The carrying value of our cash deposit accounts, trade accounts receivable, trade accounts payable, customer deposits, and dividends payable approximates fair value due to their relatively short maturity and immaterial non-performance risk. Based upon variable interest rates currently available to the Company, the fair value of our debt approximates the carrying value.

Investments

Investments	9 Months Ended
	Mar. 31, 2022
Investments [Abstract]
Investments	Investments Supplemental Employee Retirement Plan Investments: We maintain a self-directed supplemental employee retirement plan (“SERP”) in which executive employees are eligible to participate. The SERP utilizes a rabbi trust, and therefore assets in the SERP portfolio are subject to creditor claims in the event of bankruptcy. We recognize SERP investment assets on the Condensed Consolidated Balance Sheets at current fair value. A SERP liability of the same amount is recorded on the Condensed Consolidated Balance Sheets representing an obligation to distribute SERP funds to participants. The SERP investment assets are classified as trading, and accordingly, realized and unrealized gains and losses are recognized in the Other Income (Expense) section of the Condensed Consolidated Statements of Income. Adjustments made to revalue the SERP liability are also recognized in income or expense as selling and administrative expenses and offset valuation adjustments on SERP investment assets. Net unrealized holding gains (losses) for the nine months ended March 31, 2022 and 2021 were, in thousands, $(1,306) and $2,051, respectively. SERP asset and liability balances were as follows: (Amounts in Thousands) March 31, June 30, SERP investments - current asset $ 3,676 $ 3,905 SERP investments - other long-term asset 9,437 10,144 Total SERP investments $ 13,113 $ 14,049 SERP obligation - current liability $ 3,676 $ 3,905 SERP obligation - other long-term liability 9,437 10,144 Total SERP obligation $ 13,113 $ 14,049 Equity securities without readily determinable fair value: We hold a total investment of $2.0 million in a privately-held company, including $0.5 million in equity securities without readily determinable fair value. The investment in equity securities without readily determinable fair value is included in the Other Assets line of the Condensed Consolidated Balance Sheets. See Note 13 - Fair Value of Notes to Condensed Consolidated Financial Statements for more information on the valuation of these securities. We do not hold a majority voting interest and are not the variable interest primary beneficiary of the privately-held company, thus consolidation is not required.

Derivative Instruments

Derivative Instruments	9 Months Ended
	Mar. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Interest Rate Swap: We are subject to interest rate risk related to the revolving credit facility and we enter into interest rate swap agreements that are based on LIBOR to manage this exposure. The interest rate swap agreements are designated as cash flow hedges that qualify for hedge accounting under the hypothetical derivative method. Fair value adjustments are recorded as a component of Accumulated Other Comprehensive Income (“AOCI”), net of tax in the Condensed Consolidated Balance Sheets. Balances in AOCI are reclassified into earnings when transactions related to the underlying risk are settled. As of March 31, 2022 we held an interest rate swap with one bank with a notional value totaling $40.0 million and a weighted average LIBOR fixed rate of 0.834%. See Note 13 - Fair Value of Notes to Condensed Consolidated Financial Statements for information regarding the fair value of our interest rate swap. At March 31, 2022, our interest rate swap was recorded in current assets and non-current assets at $0.6 million and $1.0 million, respectively. The pre-tax balance of interest rate swap gains in AOCI as of March 31, 2022 was $1.6 million. See Note 10 - Accumulated Other Comprehensive Income of Notes to Condensed Consolidated Financial Statements for information regarding activity recorded as a component of AOCI during the three and nine months ended March 31, 2022. As of March 31, 2022, we have $0.6 million of interest rate swap gains recorded in AOCI which are expected to be reclassified into earnings within the next twelve months. Stock Warrants: We hold a total investment of $2.0 million in a privately-held company, including $1.5 million in stock warrants. The investment in stock warrants is accounted for as a derivative instrument and is included in the Other Assets line of the Condensed Consolidated Balance Sheets. The stock warrants are convertible into equity shares of the privately-held company upon achieving certain milestones. The value of the stock warrants will fluctuate primarily in relation to the value of the privately-held company's underlying securities, either providing an appreciation in value or potentially expiring with no value. During the quarter ended March 31, 2022, the change in fair value of the stock warrants was not significant. See Note 13 - Fair Value

Postemployment Benefits

Postemployment Benefits	9 Months Ended
	Mar. 31, 2022
Postemployment Benefits [Abstract]
Postemployment Benefits	Postemployment Benefits Our domestic employees participate in severance plans which provide severance benefits to eligible employees meeting the plans’ qualifications, primarily for involuntary termination without cause. The components of net periodic postemployment benefit cost applicable to our severance plans were as follows: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Service cost $ 123 $ 118 $ 388 $ 361 Interest cost 13 10 41 31 Amortization of actuarial income (129) (112) (399) (333) Net periodic benefit cost $ 7 $ 16 $ 30 $ 59 The benefit cost in the above table includes only normal recurring levels of severance activity, as estimated using an actuarial method. Unusual or non-recurring severance actions, such as restructuring actions, are not estimable using actuarial methods and are expensed in accordance with the applicable U.S. GAAP.

Stock Compensation

Stock Compensation	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock Compensation	Stock Compensation Stock-based compensation expense during the quarter and year-to-date periods ended March 31, 2022 was $1.1 million and $3.7 million, respectively, and during the quarter and year-to-date periods ended March 31, 2021, was $1.8 million and $4.0 million, respectively. The total income tax benefit for stock compensation arrangements during the quarter and year-to-date period ended March 31, 2022 was $0.3 million and $0.9 million, respectively, and during the quarter and year-to-date period ended March 31, 2021 was $0.5 million and $1.0 million, respectively. During fiscal year 2022, the following stock compensation was awarded to officers and other key employees and to members of the Board of Directors who are not employees. All awards were granted under the 2017 Stock Incentive Plan. For more information on stock compensation awards, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. Type of Award Quarter Awarded Targeted Shares or Units Grant Date Fair Value (4) Relative Total Shareholder Return Performance Units (1) 1st Quarter 63,110 $15.54 Restricted Stock Units (2) 1st Quarter 214,330 $12.57 - $13.02 Restricted Stock Units (2) 2nd Quarter 42,142 $10.42 - $11.05 Restricted Stock Units (2) 3rd Quarter 59,271 $9.02 - $9.35 Unrestricted Shares (3) 1st Quarter 8,966 $13.11 - $13.25 Unrestricted Shares (3) 2nd Quarter 9,246 $11.58 Unrestricted Shares (3) 3rd Quarter 12,246 $10.36 (1) Performance units were awarded to key officers under the Company’s Relative Total Shareholder Return program. Vesting occurs at June 30, 2024. Participants will earn from 0% to 200% of the target award depending upon how the compound annual growth rate of Kimball International common stock ranks within the peer group at the end of the performance period. The maximum number of units that can be issued under these awards, excluding forfeited awards, is 121,298. (2) Restricted stock units were awarded to officers and key employees. Vesting occurs at June 30, 2022, June 30, 2023, and June 30, 2024. Upon vesting, the outstanding number of restricted stock units and the value of dividends accumulated over the vesting period are converted to shares of common stock. (3) Unrestricted shares were awarded to non-employee members of the Board of Directors and key employees as consideration for service to Kimball International and do not have vesting periods, holding periods, restrictions on sale, or other restrictions. (4) The grant date fair value of the Relative Total Shareholder Return awards was calculated using a Monte Carlo simulation. This valuation technique includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends. The grant date fair value of the restricted stock units that receive dividends and unrestricted shares was based on the stock price at the date of the award.

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements and Supplemental Information (Policies)	9 Months Ended
	Mar. 31, 2022
Recent Accounting Pronouncements and Supplemental Information [Abstract]
Basis of Presentation	Basis of PresentationThe accompanying unaudited Condensed Consolidated Financial Statements of Kimball International, Inc. (the “Company,” “Kimball International,” “we,” “us,” or “our”) have been prepared in accordance with the instructions to Form 10-Q. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. Intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. It is suggested that these financial statements be read in conjunction with the financial statements and the notes thereto included in our latest annual report on Form 10-K. Additionally, based on the duration and severity of the current global situation involving the COVID-19 pandemic, related supply chain disruptions and inflation, the extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted:In October 2021, the Financial Accounting Standards Board issued guidance on accounting for contract assets and contract liabilities, related to revenue contracts with customers, during a business combination by the acquiring business entity. The acquirer is to measure the contract asset and contract liability as of the acquisition date as if the acquirer had originated the contracts. This is a departure from the current practice under U.S. GAAP of recognizing contract assets and contract liabilities at fair value as of the acquisition date. The guidance will be effective in our first quarter of fiscal year 2024, though early adoption is permitted. Management is unable to predict whether the adoption of this guidance will have a material impact on our financial statements.
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets: Goodwill represents the difference between the purchase price and the related underlying tangible and intangible net asset fair values resulting from business acquisitions. Goodwill is assigned to and the fair value is tested at the reporting unit level. Annually, or if conditions indicate an earlier assessment is necessary, we may assess qualitative factors to determine if it is more likely than not that the fair value is less than its carrying amount. We also have the option to bypass the qualitative assessment and proceed directly to performing the quantitative goodwill impairment test which compares the carrying value of the reporting unit to the reporting unit’s fair value to identify impairment. Under the quantitative assessment, if the fair value of the reporting unit is less than the carrying value, goodwill is written down to its fair value. The fair value is established primarily using a discounted cash flow analysis and secondarily a market approach utilizing current industry information. The calculation of the fair value of the reporting unit considers current market conditions existing at the assessment date and reporting unit specific scenarios weighted on probability of outcome. Application of the goodwill impairment test requires judgment, including the identification of reporting units, assignment of assets and liabilities to reporting units, assignment of goodwill to reporting units, and determination of the fair value of each reporting unit. This analysis requires significant judgments, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term rate of growth for our business, and determination of our weighted average cost of capital. The estimates used to calculate the fair value of a reporting unit change from year to year based on operating results, market conditions, and other factors. Changes in these estimates and assumptions could materially affect the determination of fair value and goodwill impairment for each reporting unit. While we have historically performed goodwill impairment testing annually during the second fiscal quarter, changes in circumstances may require an interim assessment of the carrying amounts of our reporting units relative to their fair values. In connection with our annual goodwill impairment test and the preparation of our financial statements, we assessed goodwill at the reporting unit level for impairment during our second quarter of fiscal year 2022 and based on our analysis our Poppin reporting unit had a carrying amount that exceeded its fair value. A forecast revision to delay future sales and earnings growth of
Impairment Or Disposal Of Intangible Assets	Other Intangible Assets reported on the Condensed Consolidated Balance Sheets consist of capitalized software, customer relationships, trade names, acquired technology, patents and trademarks, and non-compete agreements. Intangible assets are assessed for impairment when events or circumstances indicate that the carrying value may not be recoverable over the remaining lives of the assets
Intangible Assets	Capitalized software is stated at cost less accumulated amortization and is amortized using the straight-line method. During the software application development stage, capitalized costs include external consulting costs, cost of software licenses, and internal payroll and payroll-related costs for employees who are directly associated with a software project. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process re-engineering costs are expensed in the period in which they are incurred. Trade names, non-compete agreements, acquired technology, patents and trademarks are amortized on a straight-line basis over their estimated useful lives. Customer relationships are amortized based on estimated attrition rates of customers.
Impairment or disposal of long-lived assets	We utilized available market prices and management estimates to determine the fair value of impaired assets. Restructuring is included in the Restructuring Expense line item on our Condensed Consolidated Statements of Income.
Recognition of asset and liability for lease	Certain leases have terms that are dependent upon the occurrence of events, activities, or circumstances in lease agreements and incur variable lease expense driven by warehouse square footage utilized, property taxes assessed, and other non-lease component charges. Variable lease expense is presented as operating expense in our Condensed Consolidated Statements of Income and Comprehensive Income in the same line item as expense arising from fixed lease payments for operating leases.
Separation of lease and non-lease components	For all classes of assets, we do not separate non-lease components of a contract from the lease components to which they relate.
Short-term Leases	We do not recognize a right-of-use asset or lease liability for short-term leases that have a lease term of twelve months or less.
Income tax policy	In determining the quarterly provision for income taxes we use an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur.
Inventory	For interim reporting, LIFO inventories are computed based on quantities as of the end of the quarter and interim changes in price levels. Changes in quantities and price levels are reflected in the interim financial statements in the period in which they occur, except in cases where LIFO inventory liquidations are expected to be reinstated by fiscal year end.
Product Warranties	We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability periodically based on changes in historical cost trends and in certain cases where specific warranty issues become known. The product warranty liability is included on the Accrued Expenses and Other lines of our Condensed Consolidated Balance Sheets.
Fair Value	We categorize assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: • Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities. • Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets. • Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability. Our policy is to recognize transfers between these levels as of the end of each quarterly reporting period. There were no transfers between these levels during the nine months ended March 31, 2022 and 2021. There were no changes in the inputs or valuation techniques used to measure fair values compared to those disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. The following methods and assumptions were used to measure fair value: Financial Instrument Level Valuation Technique/Inputs Used Cash Equivalents: Money market funds 1 Market - Quoted market prices Trading securities: Mutual funds held in nonqualified SERP 1 Market - Quoted market prices Derivative Assets: Stock warrants 3 Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities. Derivative Asset: Interest Rate Swap 2 Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball International's non-performance risk. Contingent earn-out liability 3 Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability.
Fair Value of Financial Instruments Policy Continued	The following methods and assumptions were used to measure fair value: Financial Instrument Level Valuation Technique/Inputs Used Cash Equivalents: Money market funds 1 Market - Quoted market prices Trading securities: Mutual funds held in nonqualified SERP 1 Market - Quoted market prices Derivative Assets: Stock warrants 3 Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities. Derivative Asset: Interest Rate Swap 2 Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball International's non-performance risk. Contingent earn-out liability 3 Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability.
Fair value measurement, non-recurring policy	Certain assets are measured at fair value on a non-recurring basis. These assets are not measured at fair value on an ongoing basis but are subject to fair value adjustments when events or circumstances indicate a significant adverse effect on the fair value of the asset. Assets that are written down to fair value when impaired are not subsequently adjusted to fair value unless further impairment occurs. Non-recurring Fair Value Adjustment Level Valuation Technique/Inputs Used Impairment of Right of Use Lease Assets and Related Asset Groups 3 Income - Based on a valuation model that measures the present value of remaining lease payments less estimated sublease income at a discount rate that captures the risk associated with the future cash flows. Impairment of Goodwill 3 Income - Based on a valuation model that determines fair value based on estimated discounted future cash flows of each reporting unit, requiring the use of significant estimates and assumptions, including revenue growth rates and EBITDA margins, future market conditions and discount rates that capture the risk associated with future cash flows.
Fair value of financial instruments not carried at fair value	Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following: Financial Instrument Level Valuation Technique/Inputs Used Notes receivable 2 Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer’s non-performance risk. Equity securities without readily determinable fair value 3 Cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively.
Non-operating Income and Expense, net	Non-operating Income (Expense), net: Non-operating income and expense include the impact of such items as fair value adjustments on Supplemental Employee Retirement Plan (“SERP”) investments, amortization of actuarial income, foreign currency rate movements, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain or loss on SERP investments is offset by a change in the SERP liability that is recognized in selling and administrative expenses.

Recent Accounting Pronounceme_3

Recent Accounting Pronouncements and Supplemental Information (Tables)	9 Months Ended
	Mar. 31, 2022
Recent Accounting Pronouncements and Supplemental Information [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill are summarized as follows: (Amounts in Thousands) Gross Goodwill Accumulated Impairment Net Carrying Amount June 30, 2020 $ 12,893 $ (1,733) $ 11,160 Additions 70,802 — 70,802 June 30, 2021 83,695 (1,733) 81,962 Impairment — (34,118) (34,118) March 31, 2022 $ 83,695 $ (35,851) $ 47,844
Schedule of Finite-Lived Intangible Assets	A summary of intangible assets subject to amortization is as follows: March 31, 2022 June 30, 2021 (Amounts in Thousands) Cost Accumulated Net Value Cost Accumulated Net Value Capitalized Software $ 45,181 $ 34,992 $ 10,189 $ 43,200 $ 34,058 $ 9,142 Customer Relationships 19,050 6,016 13,034 19,050 3,936 15,114 Trade Names 36,570 5,897 30,673 36,570 3,154 33,416 Acquired Technology 7,000 1,312 5,688 7,000 559 6,441 Patents and Trademarks 354 39 315 354 16 338 Non-Compete Agreements 100 88 12 100 73 27 Other Intangible Assets $ 108,255 $ 48,344 $ 59,911 $ 106,274 $ 41,796 $ 64,478 A summary of the useful lives of intangible assets subject to amortization is as follows: Years Capitalized Software 2 to 13 Customer Relationships 10 to 20 Trade Names 10 Acquired Technology 7 Patents 14 Trademarks 15 Non-Compete Agreements 5
Components of Non-operating income (expense), net	Other General (Income) Expense includes the gain related to the sale of a warehouse during the third quarter of fiscal year 2022. Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Other General (Income) Expense $ (4,523) $ — $ (4,523) $ — Components of the Non-operating income (expense), net line, were: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Gain (Loss) on SERP Investments $ (887) $ 428 $ (300) $ 2,567 Other 17 (117) (47) (133) Non-operating income (expense), net $ (870) $ 311 $ (347) $ 2,434
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The following methods and assumptions were used to measure fair value: Financial Instrument Level Valuation Technique/Inputs Used Cash Equivalents: Money market funds 1 Market - Quoted market prices Trading securities: Mutual funds held in nonqualified SERP 1 Market - Quoted market prices Derivative Assets: Stock warrants 3 Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities. Derivative Asset: Interest Rate Swap 2 Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball International's non-performance risk. Contingent earn-out liability 3 Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability. Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following: Financial Instrument Level Valuation Technique/Inputs Used Notes receivable 2 Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer’s non-performance risk. Equity securities without readily determinable fair value 3 Cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively.

Acquisition (Tables)

Acquisition (Tables)	9 Months Ended
	Mar. 31, 2022
Business Combinations [Abstract]
Schedule of Business Acquisitions, by Acquisition	A summary of the final purchase price allocation is as follows: Purchase Price Allocation (Amounts in Thousands) Cash $ 5,768 Receivables 2,814 Inventories 15,718 Other current assets 700 Net property and equipment 975 Other intangible assets 52,394 Goodwill 70,801 Right-of-use operating lease assets 5,103 Other long-term assets 4,161 Deferred tax assets 5,836 Total Assets $ 164,270 Current maturities of long-term debt 1,252 Accounts payable 7,715 Customer deposits 2,045 Current portion of operating lease liability 1,937 Accrued expenses 5,260 Long-term debt, less current maturities 1,252 Long-term operating lease liability 2,565 Other long-term liabilities 80 Total Liabilities $ 22,106 Net Assets $ 142,164
Business Acquisition Consideration	Consideration (Amounts in Thousands) Cash $ 110,374 Contingent earn-out — fair value at acquisition date 31,790 Fair value of total consideration $ 142,164 Less: Acquired cash 5,768 Total consideration less acquired cash $ 136,396
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information summarizes the combined results of operations for Kimball International, Inc. and Poppin, Inc. as if the companies were combined as of the beginning of fiscal period presented below: (unaudited) Nine months ended March 31 (Amounts in Thousands, Except Per Share Data) 2021 Net Sales $ 442,966 Net Income (Loss) (3,187) Diluted Earnings (Loss) Per Share of Common Stock $ (0.08)

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Mar. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs	A summary of the charges recorded in connection with the second phase of the transformation restructuring plan is as follows: Three Months Ended Nine Months Ended Charges Incurred to Date March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Cash-related restructuring charges: Severance and other employee related costs $ 539 $ 1,404 $ 772 $ 4,915 $ 5,854 Facility exit costs and other cash charges 1,006 613 1,896 849 3,483 Total cash-related restructuring charges $ 1,545 $ 2,017 $ 2,668 $ 5,764 $ 9,337 Non-cash charges: Impairment of assets and accelerated depreciation 185 452 1,527 1,437 3,683 Total charges $ 1,730 $ 2,469 $ 4,195 $ 7,201 $ 13,020
Accrued Restructuring Charges Activity	A summary of the current period activity in accrued restructuring related to the second phase of the transformation restructuring plan is as follows: (Amounts in Thousands) Severance and other employee related costs Balance at June 30, 2021 $ 1,386 Additions charged to expense 788 Cash payments charged against reserve (1,645) Non-cash adjustments (25) Balance at March 31, 2022 $ 504

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Mar. 31, 2022
Revenue Recognition [Abstract]
Disaggregation of Revenue	The following table provides information about revenue by operating segment: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Millions) 2022 2021 2022 2021 Workplace $ 102.5 $ 70.0 $ 290.2 $ 249.9 Health 26.6 24.6 76.2 72.2 Hospitality 34.5 35.2 76.4 89.0 eBusiness 17.3 8.9 46.1 11.7 Total Net Sales $ 180.9 $ 138.7 $ 488.9 $ 422.8

Leases (Tables)

Leases (Tables)	9 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Components of lease expense	The components of our lease expenses are as follows: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Millions) 2022 2021 2022 2021 Operating lease expense $ 1.2 $ 1.3 $ 3.6 $ 3.1 Variable lease expense 1.1 1.2 2.8 2.5 Total lease expense $ 2.3 $ 2.5 $ 6.4 $ 5.6
Supplemental cash flow and other information related to leases	Supplemental cash flow and other information related to leases are as follows: Nine Months Ended March 31 (Amounts in Millions) 2022 2021 Cash flow information: Operating lease payments impacting lease liability $ 5.8 $ 4.2 Non-cash impact of obtaining new right-of-use assets $ 6.3 $ 5.1 As of March 31 2022 2021 Other information: Weighted-average remaining term (in years) 4.8 4.4 Weighted-average discount rate 4.4 % 4.5 %
Future minimum lease payments	The following table summarizes the future minimum lease payments as of March 31, 2022: Fiscal Year Ended (Amounts in Millions) June 30 (1) 2022 $ 1.5 2023 6.0 2024 4.5 2025 3.8 2026 2.8 Thereafter 3.9 Total lease payments $ 22.5 Less interest 2.2 Present value of lease liabilities $ 20.3

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands, Except for Per Share Data) 2022 2021 2022 2021 Net Income (Loss) $ 6,295 $ (4,529) $ (20,068) $ 19 Average Shares Outstanding for Basic EPS Calculation 36,795 36,860 36,788 36,932 Dilutive Effect of Average Outstanding Compensation Awards 266 — — 597 Average Shares Outstanding for Diluted EPS Calculation 37,061 36,860 36,788 37,529 Basic Earnings (Loss) Per Share $ 0.17 $ (0.12) $ (0.55) $ 0.00 Diluted Earnings (Loss) Per Share $ 0.17 $ (0.12) $ (0.55) $ 0.00

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Mar. 31, 2022
Inventory Disclosure [Abstract]
Schedule of Inventory, Current	Inventory components were as follows: (Amounts in Thousands) March 31, June 30, Finished products $ 56,235 $ 37,787 Work-in-process 1,829 1,320 Raw materials 48,988 33,428 Total FIFO inventory 107,052 72,535 LIFO reserve (23,507) (18,244) Total inventory $ 83,545 $ 54,291

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	During the three months ended March 31, 2022 and 2021, the changes in the balances of each component of Accumulated Other Comprehensive Income, net of tax, were as follows: Accumulated Other Comprehensive Income (Amounts in Thousands) Unrealized Investment Gain (Loss) Postemployment Benefits Net Actuarial Gain (Loss) Interest Rate Swap Gain (Loss) Accumulated Other Comprehensive Income Balance at December 31, 2021 $ — $ 2,197 $ 174 $ 2,371 Other comprehensive income (loss) before reclassifications — 185 998 1,183 Reclassification to (earnings) loss — (95) 46 (49) Net current-period other comprehensive income (loss) — 90 1,044 1,134 Balance at March 31, 2022 $ — $ 2,287 $ 1,218 $ 3,505 Balance at December 31, 2020 $ 4 $ 2,165 $ — $ 2,169 Other comprehensive income (loss) before reclassifications (3) 129 — 126 Reclassification to (earnings) loss — (83) — (83) Net current-period other comprehensive income (loss) (3) 46 — 43 Balance at March 31, 2021 $ 1 $ 2,211 $ — $ 2,212 During the nine months ended March 31, 2022 and 2021, the changes in the balances of each component of Accumulated Other Comprehensive Income, net of tax, were as follows: Accumulated Other Comprehensive Income (Amounts in Thousands) Unrealized Investment Gain (Loss) Postemployment Benefits Net Actuarial Gain (Loss) Interest Rate Swap Gain (Loss) Accumulated Other Comprehensive Income Balance at June 30, 2021 $ — $ 1,980 $ — $ 1,980 Other comprehensive income (loss) before reclassifications — 603 1,073 1,676 Reclassification to (earnings) loss — (296) 145 (151) Net current-period other comprehensive income (loss) — 307 1,218 1,525 Balance at March 31, 2022 $ — $ 2,287 $ 1,218 $ 3,505 Balance at June 30, 2020 $ 32 $ 2,105 $ — $ 2,137 Other comprehensive income (loss) before reclassifications (31) 353 — 322 Reclassification to (earnings) loss — (247) — (247) Net current-period other comprehensive income (loss) (31) 106 — 75 Balance at March 31, 2021 $ 1 $ 2,211 $ — $ 2,212
Reclassifications from Accumulated Other Comprehensive Income	The following reclassifications were made from Accumulated Other Comprehensive Income to the Condensed Consolidated Statements of Income (Loss): Reclassifications from Accumulated Other Comprehensive Income Three Months Ended Nine Months Ended Affected Line Item in the Condensed Consolidated Statements of Income (Loss) March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Postemployment Benefits Amortization of Actuarial Gain (1) $ 129 $ 112 $ 399 $ 333 Non-operating income (expense), net (34) (29) (103) (86) Benefit (Provision) for Income Taxes $ 95 $ 83 $ 296 $ 247 Net Income (Loss) Interest Rate Swap Gain (Loss) (2) $ (62) $ — $ (195) $ — Interest expense 16 — 50 — Benefit (Provision) for Income Taxes $ (46) $ — $ (145) $ — Net Income (Loss) Total Reclassifications for the Period $ 49 $ 83 $ 151 $ 247 Net Income (Loss) Amounts in parentheses indicate reductions to income. (1) See Note 16 - Postemployment Benefits of Notes to Condensed Consolidated Financial Statements for further information on postemployment benefit plans. (2) See Note 15 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements for further information on derivative instruments.

Long-Term Debt and Revolving _2

Long-Term Debt and Revolving Credit Facility (Tables)	9 Months Ended
	Mar. 31, 2022
Debt Disclosure [Abstract]
Schedule of Debt	Short-term borrowings and long-term debt consisted of the following obligations: (Amounts in Thousands) March 31, June 30, Long-term debt under revolving credit facility due October 2024; 2.46% variable interest rate at March 31, 2022 $ 58,000 $ 40,000 Other debt maturing August 2024; 9.25% fixed interest rate 79 109 Total Debt $ 58,079 $ 40,109

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Tables)	9 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule of Product Warranty Liability	Changes in the product warranty accrual for the nine months ended March 31, 2022 and 2021 were as follows: Nine Months Ended March 31 (Amounts in Thousands) 2022 2021 Product Warranty Liability at the beginning of the period $ 2,861 $ 3,190 Additions to warranty accrual (including changes in estimates) 882 1,256 Settlements made (in cash or in kind) (1,510) (1,643) Product Warranty Liability at the end of the period $ 2,233 $ 2,803

Fair Value (Tables)

Fair Value (Tables)	9 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The recurring Level 3 fair value measurements of our contingent consideration liability include the following significant unobservable inputs: Contingent Consideration Liability Fair Value Valuation Technique Unobservable Inputs Range Selected Revenue and EBITDA Based Payments $ 4.4 million Discounted Cash Flow Revenue Discount Rate 5.0% to 7.0% 5.8 % EBITDA Volatility 40.0% to 50.0% 45.0 % Revenue Volatility 8.0% to 11.0% 10.5 %
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	The following methods and assumptions were used to measure fair value: Financial Instrument Level Valuation Technique/Inputs Used Cash Equivalents: Money market funds 1 Market - Quoted market prices Trading securities: Mutual funds held in nonqualified SERP 1 Market - Quoted market prices Derivative Assets: Stock warrants 3 Market - The privately-held company is in a start-up phase. The pricing of recent purchases or sales of the investment are considered, if any, as well as positive and negative qualitative evidence, in the assessment of fair value. The value of the stock warrants fluctuates primarily in relation to the value of the privately-held company's underlying securities. Derivative Asset: Interest Rate Swap 2 Market - Based on observable market inputs using standard calculations, such as time value, forward interest rate yield curves, and current spot rates adjusted for Kimball International's non-performance risk. Contingent earn-out liability 3 Income - Based on a valuation model that measures the present value of the probable cash payments based upon the forecasted operating performance of the acquisition and a discount rate that captures the risk associated with the liability. Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include the following: Financial Instrument Level Valuation Technique/Inputs Used Notes receivable 2 Market - Price approximated based on the assumed collection of receivables in the normal course of business, taking into account the customer’s non-performance risk. Equity securities without readily determinable fair value 3 Cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. Impairment is assessed qualitatively.
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	As of March 31, 2022 and June 30, 2021, the fair values of financial assets that are measured at fair value on a recurring basis using the market or income approach are categorized as follows: March 31, 2022 (Amounts in Thousands) Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 2,008 $ — $ — $ 2,008 Derivatives: Interest rate swap contract — 1,640 — 1,640 Trading Securities: Mutual funds in nonqualified SERP 13,113 — — 13,113 Derivatives: Stock warrants — — 1,500 1,500 Total assets at fair value $ 15,121 $ 1,640 $ 1,500 $ 18,261 Liabilities Contingent earn-out liability — — 4,440 4,440 Total liabilities at fair value $ — $ — $ 4,440 $ 4,440 June 30, 2021 (Amounts in Thousands) Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 18,762 $ — $ — $ 18,762 Trading Securities: Mutual funds in nonqualified SERP 14,049 — — 14,049 Derivatives: Stock warrants — — 1,500 1,500 Total assets at fair value $ 32,811 $ — $ 1,500 $ 34,311 Liabilities Contingent earn-out liability — — 20,190 20,190 Total liabilities at fair value $ — $ — $ 20,190 $ 20,190
Non-recurring Fair Value Adjustment Technique	Non-recurring Fair Value Adjustment Level Valuation Technique/Inputs Used Impairment of Right of Use Lease Assets and Related Asset Groups 3 Income - Based on a valuation model that measures the present value of remaining lease payments less estimated sublease income at a discount rate that captures the risk associated with the future cash flows. Impairment of Goodwill 3 Income - Based on a valuation model that determines fair value based on estimated discounted future cash flows of each reporting unit, requiring the use of significant estimates and assumptions, including revenue growth rates and EBITDA margins, future market conditions and discount rates that capture the risk associated with future cash flows.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Mar. 31, 2022
Investments [Abstract]
Trading Securities (and Certain Trading Assets)	SERP asset and liability balances were as follows: (Amounts in Thousands) March 31, June 30, SERP investments - current asset $ 3,676 $ 3,905 SERP investments - other long-term asset 9,437 10,144 Total SERP investments $ 13,113 $ 14,049 SERP obligation - current liability $ 3,676 $ 3,905 SERP obligation - other long-term liability 9,437 10,144 Total SERP obligation $ 13,113 $ 14,049

Postemployment Benefits (Tables

Postemployment Benefits (Tables)	9 Months Ended
	Mar. 31, 2022
Postemployment Benefits [Abstract]
Schedule of Changes in Projected Benefit Obligations	The components of net periodic postemployment benefit cost applicable to our severance plans were as follows: Three Months Ended Nine Months Ended March 31 March 31 (Amounts in Thousands) 2022 2021 2022 2021 Service cost $ 123 $ 118 $ 388 $ 361 Interest cost 13 10 41 31 Amortization of actuarial income (129) (112) (399) (333) Net periodic benefit cost $ 7 $ 16 $ 30 $ 59

Stock Compensation (Tables)

Stock Compensation (Tables)	9 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value	For more information on stock compensation awards, refer to our Annual Report on Form 10-K for the fiscal year ended June 30, 2021. Type of Award Quarter Awarded Targeted Shares or Units Grant Date Fair Value (4) Relative Total Shareholder Return Performance Units (1) 1st Quarter 63,110 $15.54 Restricted Stock Units (2) 1st Quarter 214,330 $12.57 - $13.02 Restricted Stock Units (2) 2nd Quarter 42,142 $10.42 - $11.05 Restricted Stock Units (2) 3rd Quarter 59,271 $9.02 - $9.35 Unrestricted Shares (3) 1st Quarter 8,966 $13.11 - $13.25 Unrestricted Shares (3) 2nd Quarter 9,246 $11.58 Unrestricted Shares (3) 3rd Quarter 12,246 $10.36 (1) Performance units were awarded to key officers under the Company’s Relative Total Shareholder Return program. Vesting occurs at June 30, 2024. Participants will earn from 0% to 200% of the target award depending upon how the compound annual growth rate of Kimball International common stock ranks within the peer group at the end of the performance period. The maximum number of units that can be issued under these awards, excluding forfeited awards, is 121,298. (2) Restricted stock units were awarded to officers and key employees. Vesting occurs at June 30, 2022, June 30, 2023, and June 30, 2024. Upon vesting, the outstanding number of restricted stock units and the value of dividends accumulated over the vesting period are converted to shares of common stock. (3) Unrestricted shares were awarded to non-employee members of the Board of Directors and key employees as consideration for service to Kimball International and do not have vesting periods, holding periods, restrictions on sale, or other restrictions. (4) The grant date fair value of the Relative Total Shareholder Return awards was calculated using a Monte Carlo simulation. This valuation technique includes estimating the movement of stock prices and the effects of volatility, interest rates, and dividends. The grant date fair value of the restricted stock units that receive dividends and unrestricted shares was based on the stock price at the date of the award.

Recent Accounting Pronounceme_4

Recent Accounting Pronouncements and Supplemental Information - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Accounting Standards and Supplemental Information [Line Items]
Goodwill impairment	$ 0	$ 34,100	$ 0	$ 34,118	$ 0
Amortization	2,358		$ 2,510	7,212	$ 4,212
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of fiscal year	2,462			2,462
Expected amortization expense, year one	9,060			9,060
Expected amortization expense, year two	8,454			8,454
Expected amortization expense, year three	8,167			8,167
Expected amortization expense, year four	7,716			7,716
Expected amortization expense, thereafter	24,051			24,051
Indefinite-lived intangible assets (excluding goodwill)	$ 0			0
Poppin, Inc.
Accounting Standards and Supplemental Information [Line Items]
Goodwill impairment				$ 34,100

Recent Accounting Pronounceme_5

Recent Accounting Pronouncements and Supplemental Information - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021	Jun. 30, 2020
Goodwill [Roll Forward]
Goodwill in the beginning of the period				$ 83,695	$ 12,893	$ 12,893
Accumulated Impairment	$ (35,851)			(35,851)		(1,733)	$ (1,733)
Net Carrying Amount, beginning balance				81,962	11,160	11,160
Additions						70,802
Impairment	0	$ (34,100)	$ 0	(34,118)	$ 0
Goodwill at the end of the period	83,695			83,695		83,695
Net Carrying Amount, Ending balance	$ 47,844			$ 47,844		$ 81,962

Recent Accounting Pronounceme_6

Recent Accounting Pronouncements and Supplemental Information - Schedule of Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Jun. 30, 2021
Finite-Lived Intangible Assets
Cost	$ 108,255	$ 106,274
Accumulated Amortization	48,344	41,796
Net Value	59,911	64,478
Capitalized Software
Finite-Lived Intangible Assets
Cost	45,181	43,200
Accumulated Amortization	34,992	34,058
Net Value	$ 10,189	9,142
Capitalized Software | Minimum
Finite-Lived Intangible Assets
Useful life	2 years
Capitalized Software | Maximum
Finite-Lived Intangible Assets
Useful life	13 years
Customer Relationships
Finite-Lived Intangible Assets
Cost	$ 19,050	19,050
Accumulated Amortization	6,016	3,936
Net Value	$ 13,034	15,114
Customer Relationships | Minimum
Finite-Lived Intangible Assets
Useful life	10 years
Customer Relationships | Maximum
Finite-Lived Intangible Assets
Useful life	20 years
Trade Names
Finite-Lived Intangible Assets
Cost	$ 36,570	36,570
Accumulated Amortization	5,897	3,154
Net Value	$ 30,673	33,416
Useful life	10 years
Acquired Technology
Finite-Lived Intangible Assets
Cost	$ 7,000	7,000
Accumulated Amortization	1,312	559
Net Value	$ 5,688	6,441
Useful life	7 years
Patents and Trademarks
Finite-Lived Intangible Assets
Cost	$ 354	354
Accumulated Amortization	39	16
Net Value	315	338
Non-Compete Agreements
Finite-Lived Intangible Assets
Cost	100	100
Accumulated Amortization	88	73
Net Value	$ 12	$ 27
Useful life	5 years
Patents
Finite-Lived Intangible Assets
Useful life	14 years
Trademarks
Finite-Lived Intangible Assets
Useful life	15 years

Recent Accounting Pronounceme_7

Recent Accounting Pronouncements and Supplemental Information - Components of Non-operating income (expense), net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Recent Accounting Pronouncements and Supplemental Information [Abstract]
Gain (Loss) on SERP Investments	$ (887)	$ 428	$ (300)	$ 2,567
Other	17	(117)	(47)	(133)
Non-operating income (expense), net	(870)	311	(347)	2,434
Other General (Income) Expense	$ (4,523)	$ 0	$ (4,523)	$ 0

Acquisition - Narrative (Detail

Acquisition - Narrative (Details) - USD ($) $ in Thousands	Dec. 09, 2020	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Business Acquisition [Line Items]
Long-term earn-out liability		$ 4,440		$ 4,440		$ 20,190
Net sales		180,918	$ 138,676	488,931	$ 422,817
Net loss		(6,295)	$ 4,529	20,068	$ (19)
Poppin, Inc.
Business Acquisition [Line Items]
Payments to acquire business	$ 110,374
Contingent earn-out liability	$ 31,800
Long-term earn-out liability		4,400		4,400		$ 20,200
Net sales		17,200		45,900
Net loss		$ 3,600		$ 10,600

Acquisition - Schedule of Purch

Acquisition - Schedule of Purchase Price Allocation for Acquisition (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021	Dec. 09, 2020	Jun. 30, 2020
Assets
Goodwill	$ 47,844	$ 81,962		$ 11,160
Poppin, Inc.
Assets
Cash			$ 5,768
Receivables			2,814
Inventories			15,718
Other current assets			700
Net property and equipment			975
Other intangible assets			52,394
Goodwill			70,801
Right-of-use operating lease assets			5,103
Other long-term assets			4,161
Deferred tax assets			5,836
Total Assets			164,270
Liabilities
Current maturities of long-term debt			1,252
Accounts payable			7,715
Customer deposits			2,045
Current portion of operating lease liability			1,937
Accrued expenses			5,260
Long-term debt, less current maturities			1,252
Long-term operating lease liability			2,565
Other long-term liabilities			80
Total Liabilities			22,106
Net Assets			$ 142,164

Acquisition - Schedule of Consi

Acquisition - Schedule of Consideration for Acquisition (Details) - USD ($) $ in Thousands	Dec. 09, 2020	Mar. 31, 2022	Mar. 31, 2021
Business Acquisition, Contingent Consideration [Line Items]
Total consideration less acquired cash		$ 0	$ 101,478
Poppin, Inc.
Business Acquisition, Contingent Consideration [Line Items]
Cash	$ 110,374
Contingent earn-out — fair value at acquisition date	31,790
Fair value of total consideration	142,164
Less: Acquired cash	5,768
Total consideration less acquired cash	$ 136,396

Acquisition - Pro Forma Informa

Acquisition - Pro Forma Information (Details) - Poppin, Inc. $ / shares in Units, $ in Thousands	9 Months Ended
	Mar. 31, 2021USD ($)$ / shares
Business Acquisition [Line Items]
Net Sales	$ 442,966
Net Income (Loss)	$ (3,187)
Diluted Earnings (Loss) Per Share of Common Stock (in dollars per share) | $ / shares	$ (0.08)

Restructuring - Narrative (Deta

Restructuring - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Restructuring Expense and Other Related Items
Restructuring expense	$ 1,730	$ 2,617	$ 4,195	$ 8,473
Transformation Restructuring Plan
Restructuring Expense and Other Related Items
Restructuring expense	1,730	$ 2,469	4,195	$ 7,201
Effect on future earnings, amount			18,000
Restructuring and related cost expected cost, fiscal 2021	6,000		6,000
Restructuring and related cost expected cost, thereafter	3,500		$ 3,500
Percentage of restructuring costs expected in cash			65.00%
Transformation Restructuring Plan | Minimum
Restructuring Expense and Other Related Items
Restructuring and related expected costs	17,500		$ 17,500
Transformation Restructuring Plan | Minimum | Severance and other employee related costs
Restructuring Expense and Other Related Items
Restructuring and related expected costs	5,500		5,500
Transformation Restructuring Plan | Minimum | Facility exit costs and other charges
Restructuring Expense and Other Related Items
Restructuring and related expected costs	6,000		6,000
Transformation Restructuring Plan | Minimum | Impairment of assets and accelerated depreciation
Restructuring Expense and Other Related Items
Restructuring and related expected costs	6,000		6,000
Transformation Restructuring Plan | Maximum
Restructuring Expense and Other Related Items
Restructuring and related expected costs	18,500		18,500
Transformation Restructuring Plan | Maximum | Severance and other employee related costs
Restructuring Expense and Other Related Items
Restructuring and related expected costs	6,000		6,000
Transformation Restructuring Plan | Maximum | Facility exit costs and other charges
Restructuring Expense and Other Related Items
Restructuring and related expected costs	6,200		6,200
Transformation Restructuring Plan | Maximum | Impairment of assets and accelerated depreciation
Restructuring Expense and Other Related Items
Restructuring and related expected costs	$ 6,300		$ 6,300

Restructuring - Charges related

Restructuring - Charges related to Transformation Restructuring Plan (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Restructuring Expense and Other Related Items
Restructuring expense	$ 1,730	$ 2,617	$ 4,195	$ 8,473
Transformation Restructuring Plan
Restructuring Expense and Other Related Items
Restructuring expense	1,730	2,469	4,195	7,201
Charges Incurred to Date	13,020		13,020
Transformation Restructuring Plan | Cash-related restructuring charges:
Restructuring Expense and Other Related Items
Restructuring expense	1,545	2,017	2,668	5,764
Charges Incurred to Date	9,337		9,337
Transformation Restructuring Plan | Cash-related restructuring charges: | Severance and other employee related costs
Restructuring Expense and Other Related Items
Restructuring expense	539	1,404	772	4,915
Charges Incurred to Date	5,854		5,854
Transformation Restructuring Plan | Cash-related restructuring charges: | Facility exit costs and other charges
Restructuring Expense and Other Related Items
Restructuring expense	1,006	613	1,896	849
Charges Incurred to Date	3,483		3,483
Transformation Restructuring Plan | Non-cash charges: | Impairment of assets and accelerated depreciation
Restructuring Expense and Other Related Items
Restructuring expense	185	$ 452	1,527	$ 1,437
Charges Incurred to Date	$ 3,683		$ 3,683

Restructuring - Current Period

Restructuring - Current Period activity in accrued restructuring related to Transformation Restructuring Reserve (Details) - Severance and other employee related costs - Transformation Restructuring Plan $ in Thousands	9 Months Ended
	Mar. 31, 2022USD ($)
Restructuring Reserve [Roll Forward]
Balance at the beginning of the period	$ 1,386
Additions charged to expense	788
Cash payments charged against reserve	(1,645)
Non-cash adjustments	(25)
Balance at the end of the period	$ 504

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Disaggregation of Revenue [Line Items]
Net Sales	$ 180,918	$ 138,676	$ 488,931	$ 422,817
Workplace
Disaggregation of Revenue [Line Items]
Net Sales	102,500	70,000	290,200	249,900
Health
Disaggregation of Revenue [Line Items]
Net Sales	26,600	24,600	76,200	72,200
Hospitality
Disaggregation of Revenue [Line Items]
Net Sales	34,500	35,200	76,400	89,000
eBusiness
Disaggregation of Revenue [Line Items]
Net Sales	$ 17,300	$ 8,900	$ 46,100	$ 11,700

Revenue - Narrative (Details)

Revenue - Narrative (Details) $ in Millions	9 Months Ended
	Mar. 31, 2022USD ($)segment
Revenue Recognition and Deferred Revenue [Abstract]
Number of operating segments | segment	4
Customer deposit balance | $	$ 23.5

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Finance lease liability	$ 0	$ 0
Operating lease, impairment loss		$ 0.7	$ 0.2
Other Operating Income (Expense)
Sale Leaseback Transaction [Line Items]
Gain on completed sale leaseback transaction	$ 4.5

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Operating lease expense	$ 1.2	$ 1.3	$ 3.6	$ 3.1
Variable lease expense	1.1	1.2	2.8	2.5
Total lease expense	$ 2.3	$ 2.5	$ 6.4	$ 5.6

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow relating to Leases (Details) - USD ($) $ in Millions	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Leases [Abstract]
Operating lease payments impacting lease liability	$ 5.8	$ 4.2
Non-cash impact of obtaining new right-of-use assets	$ 6.3	$ 5.1
Weighted-average remaining term (in years)	4 years 9 months 18 days	4 years 4 months 24 days
Weighted-average discount rate	4.40%	4.50%

Leases - Summary of Future Leas

Leases - Summary of Future Lease Payments (Details) $ in Millions	Mar. 31, 2022USD ($)
Leases [Abstract]
2022	$ 1.5
2023	6
2024	4.5
2025	3.8
2026	2.8
Thereafter	3.9
Total lease payments	22.5
Less interest	2.2
Present value of lease liabilities	$ 20.3

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of EPS Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Net income (loss)	$ 6,295	$ (4,529)	$ (20,068)	$ 19
Average Number of Shares Outstanding - Basic (in shares)	36,795	36,860	36,788	36,932
Dilutive Effect of Average Outstanding Compensation Awards (in shares)	266	0	0	597
Average Number of Shares Outstanding - Diluted (in shares)	37,061	36,860	36,788	37,529
Basic Earnings (Loss) Per Share (in dollars per share)	$ 0.17	$ (0.12)	$ (0.55)	$ 0
Diluted Earnings (Loss) Per Share (in dollars per share)	$ 0.17	$ (0.12)	$ (0.55)	$ 0

Earnings Per Share - Narrative

Earnings Per Share - Narrative (Details) - shares shares in Thousands	3 Months Ended	9 Months Ended
	Mar. 31, 2021	Mar. 31, 2022
Restricted Stock Units (RSUs)
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	752	753
Relative Total Shareholder Return
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	166	173

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation percent	(9.30%)	39.80%	(3.30%)	102.10%

Inventories - Inventory Compone

Inventories - Inventory Components (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Inventory Disclosure [Abstract]
Finished products	$ 56,235	$ 37,787
Work-in-process	1,829	1,320
Raw materials	48,988	33,428
Total FIFO inventory	107,052	72,535
LIFO reserve	(23,507)	(18,244)
Total inventory	$ 83,545	$ 54,291

Inventories - Narrative (Detail

Inventories - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Inventory Disclosure [Abstract]
Effect of LIFO inventory on expense	$ 1,600	$ 300	$ 5,300	$ 800
Effect of LIFO inventory on income	$ 1,600	$ 400	$ 1,600	$ 600

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income- Schedule of Balances of Each Component (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Accumulated Other Comprehensive Income
Balance at the beginning of the period	$ 206,664	$ 244,012	$ 239,670	$ 244,796
Other comprehensive income (loss) before reclassifications	1,183	126	1,676	322
Reclassification to (earnings) loss	(49)	(83)	(151)	(247)
Net current-period other comprehensive income (loss)	1,134	43	1,525	75
Balance at the end of the period	212,000	236,459	212,000	236,459
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income
Balance at the beginning of the period	2,371	2,169	1,980	2,137
Balance at the end of the period	3,505	2,212	3,505	2,212
Unrealized Investment Gain (Loss)
Accumulated Other Comprehensive Income
Balance at the beginning of the period	0	4	0	32
Other comprehensive income (loss) before reclassifications	0	(3)	0	(31)
Reclassification to (earnings) loss	0	0	0	0
Net current-period other comprehensive income (loss)	0	(3)	0	(31)
Balance at the end of the period	0	1	0	1
Postemployment Benefits Net Actuarial Gain (Loss)
Accumulated Other Comprehensive Income
Balance at the beginning of the period	2,197	2,165	1,980	2,105
Other comprehensive income (loss) before reclassifications	185	129	603	353
Reclassification to (earnings) loss	(95)	(83)	(296)	(247)
Net current-period other comprehensive income (loss)	90	46	307	106
Balance at the end of the period	2,287	2,211	2,287	2,211
Interest Rate Swap Gain (Loss)
Accumulated Other Comprehensive Income
Balance at the beginning of the period	174	0	0	0
Other comprehensive income (loss) before reclassifications	998	0	1,073	0
Reclassification to (earnings) loss	46	0	145	0
Net current-period other comprehensive income (loss)	1,044	0	1,218	0
Balance at the end of the period	$ 1,218	$ 0	$ 1,218	$ 0

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income - Reclassifications from Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Reclassification Adjustment from Accumulated Other Comprehensive Income
Nonoperating Income (Expense)	$ (1,235)	$ 193	$ (1,192)	$ 2,419
Provision (Benefit) for Income Taxes	(534)	(2,992)	650	(919)
Net income (loss)	6,295	(4,529)	(20,068)	19
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment from Accumulated Other Comprehensive Income
Net income (loss)	49	83	151	247
Reclassification out of Accumulated Other Comprehensive Income | Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Reclassification Adjustment from Accumulated Other Comprehensive Income
Nonoperating Income (Expense)	129	112	399	333
Provision (Benefit) for Income Taxes	(34)	(29)	(103)	(86)
Net income (loss)	95	83	296	247
Reclassification out of Accumulated Other Comprehensive Income | AOCI, Derivative Qualifying as Hedge, Excluded Component, Noncontrolling Interest
Reclassification Adjustment from Accumulated Other Comprehensive Income
Nonoperating Income (Expense)	(62)	0	(195)	0
Provision (Benefit) for Income Taxes	16	0	50	0
Net income (loss)	$ (46)	$ 0	$ (145)	$ 0

Long-Term Debt and Revolving _3

Long-Term Debt and Revolving Credit Facility - Schedule of Short-term and Long-term Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Debt Instrument [Line Items]
Total Debt	$ 58,079	$ 40,109
Revolving Credit Facility
Debt Instrument [Line Items]
Interest rate, stated percentage	2.46%
Long-term debt under revolving credit facility due October 2024; 2.46% variable interest rate at March 31, 2022	$ 58,000	40,000
Other Debt
Debt Instrument [Line Items]
Interest rate, stated percentage	9.25%
Other debt	$ 79	$ 109

Long-Term Debt and Revolving _4

Long-Term Debt and Revolving Credit Facility - Narrative (Details) $ in Thousands	9 Months Ended
	Mar. 31, 2022USD ($)
Debt Instrument [Line Items]
Maturities year one	$ 33
Maturities year two	36
Maturities year three	58,010
Maximum borrowing capacity	125,000
Line of credit facility, remaining borrowing capacity	65,500
Interest Rate Swap | Designated as Hedging Instrument
Debt Instrument [Line Items]
Derivative notional amount	40,000
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity upon request	$ 200,000
Minimum | Revolving Credit Facility
Debt Instrument [Line Items]
Unused capacity, commitment fee percentage (basis points)	0.20%
Maximum | Revolving Credit Facility
Debt Instrument [Line Items]
Amount available for letters of credit	$ 10,000
Unused capacity, commitment fee percentage (basis points)	0.30%
Financial Standby Letter of Credit
Debt Instrument [Line Items]
Letters of credit, amount	$ 1,500

Commitments and Contingent Li_3

Commitments and Contingent Liabilities - Narrative (Details) $ in Thousands	Mar. 31, 2022USD ($)
Financial Standby Letter of Credit
Guarantor Obligations
Letters of credit, amount	$ 1,500
Standby Letters of Credit
Guarantor Obligations
Loss contingency accrual	$ 0

Commitments and Contingent Li_4

Commitments and Contingent Liabilities - Product Warranty (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Product Warranty Liability at the beginning of the period	$ 2,861	$ 3,190
Additions to warranty accrual (including changes in estimates)	882	1,256
Settlements made (in cash or in kind)	(1,510)	(1,643)
Product Warranty Liability at the end of the period	$ 2,233	$ 2,803

Fair Value - Narrative (Details

Fair Value - Narrative (Details) $ in Thousands	3 Months Ended			9 Months Ended
	Mar. 31, 2022USD ($)	Dec. 31, 2021USD ($)	Mar. 31, 2021USD ($)	Mar. 31, 2022USD ($)showroom	Mar. 31, 2021USD ($)	Jun. 30, 2021USD ($)	Dec. 09, 2020USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Changes in inputs and valuation techniques | showroom				0
Long-term earn-out liability	$ 4,440			$ 4,440		$ 20,190
Contingent Earn-out (Gain) Loss	2,200			(15,750)	$ 0
Operating lease, impairment loss				700	200
Goodwill impairment	0	$ (34,100)	$ 0	(34,118)	$ 0
Poppin, Inc.
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Contingent earn-out liability							$ 31,800
Contingent consideration, expected payments, low range	0			0
Contingent consideration, expected payments, high range	5,000			5,000
Long-term earn-out liability	4,400			4,400		$ 20,200
Goodwill impairment				(34,100)
Poppin, Inc. | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Contingent earn-out liability	$ 65,000			$ 65,000

Fair Value - Recurring Fair Val

Fair Value - Recurring Fair Value Measurements, Unobservable Input Reconciliation (Details) $ in Thousands	Mar. 31, 2022USD ($)	Jun. 30, 2021USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total earn-out liability	$ 4,440	$ 20,190
Poppin, Inc.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Total earn-out liability	$ 4,400	$ 20,200
Revenue Discount Rate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.058
Revenue Discount Rate | Minimum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.050
Revenue Discount Rate | Maximum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.070
EBITDA Volatility
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.450
EBITDA Volatility | Minimum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.400
EBITDA Volatility | Maximum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.500
Revenue Volatility
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.105
Revenue Volatility | Minimum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.080
Revenue Volatility | Maximum
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Measurement input	0.110

Fair Value - Recurring Fair V_2

Fair Value - Recurring Fair Value Measurements (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Assets
Trading Securities: Mutual funds in nonqualified SERP	$ 13,113	$ 14,049
Fair Value, Measurements, Recurring
Assets
Total assets at fair value	18,261	34,311
Liabilities
Contingent earn-out liability	4,440	20,190
Total liabilities at fair value	4,440	20,190
Fair Value, Measurements, Recurring | Warrant
Assets
Derivatives: Stock warrants	1,500	1,500
Fair Value, Measurements, Recurring | Interest Rate Swap
Assets
Derivatives: Stock warrants	1,640
Fair Value, Measurements, Recurring | Money Market Funds
Assets
Cash equivalents: Money market funds	2,008	18,762
Fair Value, Measurements, Recurring | Mutual Fund
Assets
Trading Securities: Mutual funds in nonqualified SERP	13,113	14,049
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1
Assets
Total assets at fair value	15,121	32,811
Liabilities
Contingent earn-out liability	0	0
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Warrant
Assets
Derivatives: Stock warrants	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Interest Rate Swap
Assets
Derivatives: Stock warrants	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Money Market Funds
Assets
Cash equivalents: Money market funds	2,008	18,762
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | Mutual Fund
Assets
Trading Securities: Mutual funds in nonqualified SERP	13,113	14,049
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2
Assets
Total assets at fair value	1,640	0
Liabilities
Contingent earn-out liability	0	0
Total liabilities at fair value	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Warrant
Assets
Derivatives: Stock warrants	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Interest Rate Swap
Assets
Derivatives: Stock warrants	1,640
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Money Market Funds
Assets
Cash equivalents: Money market funds	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | Mutual Fund
Assets
Trading Securities: Mutual funds in nonqualified SERP	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3
Assets
Total assets at fair value	1,500	1,500
Liabilities
Contingent earn-out liability	4,440	20,190
Total liabilities at fair value	4,440	20,190
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Warrant
Assets
Derivatives: Stock warrants	1,500	1,500
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Interest Rate Swap
Assets
Derivatives: Stock warrants	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Money Market Funds
Assets
Cash equivalents: Money market funds	0	0
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | Mutual Fund
Assets
Trading Securities: Mutual funds in nonqualified SERP	$ 0	$ 0

Investments - Supplemental Empl

Investments - Supplemental Employee Retirement Investments Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Investments [Abstract]
Unrealized holding gains (losses)	$ (1,306)	$ 2,051

Investments - Supplemental Em_2

Investments - Supplemental Employee Retirement Plan Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Jun. 30, 2021
Schedule of Trading Securities and Other Trading Assets
Total SERP investments	$ 13,113	$ 14,049
Total SERP obligation	13,113	14,049
SERP investments - current asset
Schedule of Trading Securities and Other Trading Assets
Total SERP investments	3,676	3,905
Total SERP obligation	3,676	3,905
SERP investments - other long-term asset
Schedule of Trading Securities and Other Trading Assets
Total SERP investments	9,437	10,144
Total SERP obligation	$ 9,437	$ 10,144

Investments - Investments - Equ

Investments - Investments - Equity securities without readily determinable fair value Textuals (Details) $ in Millions	Mar. 31, 2022USD ($)
Investment owned, at cost	$ 2
Other Assets | Preferred Stock
Equity securities without readily determinable fair value	$ 0.5

Derivative Instruments (Details

Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021	Jun. 30, 2021
Derivative [Line Items]
Interest rate contract losses in AOCI	$ 1,345	$ 0	$ 1,446	$ 0
Investment owned, at cost	2,000		2,000
Interest Rate Swap
Derivative [Line Items]
Interest rate contract losses in AOCI			1,600
Interest rate swap contract losses expected to be reclassified into earnings in the next twelve months			600
Designated as Hedging Instrument | Interest Rate Swap
Derivative [Line Items]
Derivative notional amount	$ 40,000		$ 40,000
Designated as Hedging Instrument | Interest Rate Swap | London Interbank Offered Rate (LIBOR) Swap Rate
Derivative [Line Items]
Derivative, interest rate	0.834%		0.834%
Designated as Hedging Instrument | Other Current Assets | Interest Rate Swap
Derivative [Line Items]
Derivative asset, fair value, gross asset	$ 600		$ 600
Designated as Hedging Instrument | Other Noncurrent Assets | Interest Rate Swap
Derivative [Line Items]
Derivative asset, fair value, gross asset	1,000		1,000
Fair Value, Measurements, Recurring | Interest Rate Swap
Derivative [Line Items]
Derivative asset, fair value, gross asset	1,640		1,640
Fair Value, Measurements, Recurring | Warrant
Derivative [Line Items]
Derivative asset, fair value, gross asset	1,500		1,500		$ 1,500
Fair Value, Measurements, Recurring | Not Designated as Hedging Instrument | Other Assets | Warrant
Derivative [Line Items]
Derivative asset, fair value, gross asset	$ 1,500		$ 1,500

Postemployment Benefits (Detail

Postemployment Benefits (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Postemployment Benefits [Abstract]
Service cost	$ 123	$ 118	$ 388	$ 361
Interest cost	13	10	41	31
Amortization of actuarial income	(129)	(112)	(399)	(333)
Net periodic benefit cost	$ 7	$ 16	$ 30	$ 59

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Share-based compensation expense	$ 1.1	$ 1.8	$ 3.7	$ 4
Share-based payment arrangement, expense, tax benefit	$ 0.3	$ 0.5	$ 0.9	$ 1

Stock Compensation - Schedule o

Stock Compensation - Schedule of Awards (Details) - $ / shares	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021	Sep. 30, 2021
Relative Total Shareholder Return
Share-based Compensation Arrangement by Share-based Payment Award
Targeted Shares or Units (in shares)			63,110
Grant Date Fair Value (in dollars per share)			$ 15.54
Relative Total Shareholder Return | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Payout percentage	0.00%
Relative Total Shareholder Return | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Payout percentage	200.00%
Number of shares authorized (in shares)	121,298
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award
Targeted Shares or Units (in shares)	59,271	42,142	214,330
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Grant Date Fair Value (in dollars per share)	$ 9.02	$ 10.42	$ 12.57
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Grant Date Fair Value (in dollars per share)	$ 9.35	$ 11.05	$ 13.02
Unrestricted Shares
Share-based Compensation Arrangement by Share-based Payment Award
Targeted Shares or Units (in shares)	12,246	9,246	8,966
Grant Date Fair Value (in dollars per share)		$ 11.58
Unrestricted Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Grant Date Fair Value (in dollars per share)	$ 10.36		$ 13.11
Unrestricted Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Grant Date Fair Value (in dollars per share)			$ 13.25